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Section A: Literature Review of ‘Dual Diagnosis’ Treatment Motivation 
This paper reviews the clinical and risk implications of dual diagnosis along with the 
treatment context. The value of gathering firsthand accounts of services users to inform the 
planning and delivery of healthcare is touched on. The second part of the paper centres on 
theories of motivation and how they might be applied to help explain low rates of dual 
diagnosis treatment uptake and engagement. Finally, gaps in the literature are highlighted 
with recommendations for further research. 
Section B: Service User and Clinician Perspectives on ‘Dual Diagnosis’ Treatment 
Motivation: A narrative analysis 
This study used a narrative approach to explore service user‟ and clinician' understandings 
of treatment motivation and engagement in relation to people with dual diagnosis. The 
outcomes suggest that the factors underpinning treatment motivation and engagement among 
this population are similar to those thought to be associated with addictions and mental health 
conditions generally although their relative influence and interaction effect might be 
different. It is suggested that negative perceptions of services, difficulties with trust, and 
therapeutic relationship are particularly important issues among dual diagnosis populations. 
The implications of the study are discussed as well as recommendations for future research. 
Section C: Critical Appraisal 
This paper provides a general overview of narrative research, including strengths and 
limitations as they relate to this study. With reference to the literature, clinical and theoretical 
implications are elaborated along with recommendations for future research. The author‟s 
critical self-reflections regarding the process of initiating, carrying out and completing the 
study are highlighted.  Following this, there is a section on the ethical considerations of the 
study. Finally, the measures taken to ensure the quality of the study and maximise internal 
consistency are presented. 
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Abstract 
This paper begins with a review of dual diagnosis, co-existing mental health and substance 
use disorder, and its clinical, social and risk implications. The treatment context in relation to 
dual diagnosis is discussed with reference to the evidence base and best practice guidelines. 
The value of gathering firsthand accounts of services users to inform the planning and 
delivery of healthcare is touched on. The second part of the paper centres on theories of 
motivation and how they might be applied to help explain low rates of dual diagnosis 
treatment uptake and engagement. Finally, gaps in the literature are highlighted with 
recommendations for further research into dual diagnosis treatment motivation and its 
relationship with treatment engagement. 
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Introduction 
Dual diagnosis, co-existing mental health and substance use disorder, is arguably the 
single most challenging issue facing adult mental health services. In recent years, various 
agencies and interested parties have sought to improve treatment provision for this 
population. A particular problem traditionally is that mental health and substance misuse 
services have operated separately and that neither, in isolation, is suitable for people with a 
dual diagnosis (Department of Health, 2002). To address this, services across the UK are 
developing integrated treatment programmes, pooling mental health and substance misuse 
expertise and resources. Although inconclusive, early outcome data for people completing 
these programmes is encouraging. Perhaps the biggest concern is poor treatment uptake and 
engagement, particularly for those who have most needs (e.g. Bellack, 2007). 
 
In research and clinically, theories and measures of motivation developed in the addictions 
field have been applied to dual diagnosis to explain the low rates of treatment initiation and 
engagement (e.g. Nidecker, Bennett, Gjobalaj-Marovic, Rachbeisel & Bellack, 2009). 
Increasingly, the wisdom of this and the concept of motivation for health behaviour change 
more generally have been questioned in the literature. Although inconclusive, there is 
evidence to suggest that the mechanisms and processes of treatment motivation and 
engagement among people with dual diagnosis are different than the mechanisms and 
processes of treatment motivation and engagement among substance misuse service users 
generally and that they need to be conceptualised separately (Bellack, 2007). To test this, 
further research is needed to explore how motivation relates specifically to dual diagnosis 
treatment seeking or uptake and engagement. In the current paper, to provide context, dual 
diagnosis definitions, prevalence, aetiology, implications, services and treatments are 
discussed. Recent attempts in the literature to clarify motivation theory are considered as are 
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local and national initiatives to increase the accessibility of mental health and substance 
misuse services. 
 
Search Method 
A systematic search of PsychINFO, Pubmed, SAGE publications, Web of Knowledge and 
the Chochrane library was carried out using the following combinations of search terms: 
[dual diagnosis or drug abuse or addiction] and [treatment or motivation or engagement or 
readiness to change]. In total, 25 articles were identified. Two papers were discarded because 
they were not written in the English language. Reference lists of the 23 remaining articles 
were searched by hand. 
 
Conceptualising Dual Diagnosis 
In theory, dual diagnosis can encompass multiple interactions of mental disorder, 
personality disorder and learning disability co-existing with various types and levels of single 
or poly substance misuse or dependence syndrome (DoH, 2002). However, in practice, 
teasing apart the relative impact of these problems and their interaction effects represents a 
considerable challenge. Also, the term diagnosis is not without problems as it runs the risk of 
pathologising complex life issues (Bentall, 2005). In the current review, dual diagnosis will 
be referred to as dual disorder (DD) unless describing a specific service or treatment 
programme. 
 
Typically, DD refers to individuals with psychiatric disorder who also misuse illicit 
substances, alcohol or non-prescribed medication, often in combination, irrespective of 
whether or not they meet the criteria for a dependence syndrome. According to DSM-IV, 
people with DD can be subdivided into two separate but overlapping categories; those with 
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“both a major substance disorder and a major psychiatric illness” (Williams, 2002, p. 3) and 
those who use substances in a manner that “affects the course and treatment of their mental 
illness” (Williams, 2002, p. 3). A distinction is made between DD and substance-induced 
mental disorder; the latter referring to the occurrence of psychotic symptoms during or for a 
limited time following drug intoxication or withdrawal states. 
 
How substance misuse and dependence are defined is also important. Broadly speaking, 
substance misuse refers to problematic drug use including but not restricted to dependency or 
addiction. According to The Royal College of Psychiatrists (1987), substance misuse is “any 
taking of a drug which harms or threatens to harm the physical or mental health or social 
well-being of an individual, or other individuals, or of society at large, or which is illegal” (p. 
17). As defined by DSM-IV (American Psychiatric Association, 2000), drug dependence is 
“a cluster of cognitive, behavioural and physiological symptoms that indicate a person has 
impaired control of psychoactive substance use and continues use of the substance despite 
adverse consequences” (p. 192). 
 
Prevalence of Dual Disorder. 
Weaver et al. (2003) carried out research into the prevalence of DD in the UK. According 
to this study, 74.5% of referrals to community substance misuse services had one of the 
following disorders: psychosis (7.9%), personality disorder (37%), severe depression (26%) 
or severe anxiety (19%). One in three met DSM-IV criteria for more than one co-occurring 
mental health disorder. In community mental health services, 39.9% of referrals had misused 
substances during the previous twelve months. Half met DSM-IV criteria for dependence 
syndrome and a third were poly-drug users. Experts in the field believe these figures are now 
considerably higher, particularly in socially deprived urban areas (DoH, 2002). 
6 
Running Head: Dual Diagnosis Treatment Motivation 
 
High levels of DD are also found in UK prisons and psychiatric inpatient settings. 
According to The Office of National Statistics, 40% of men on remand are dependent on 
substances; 79% of whom also have at least one co-occurring mental health disorder (DoH, 
2002). For people detained in psychiatric hospital, the prevalence of substance misuse and 
dependence ranges between 15% and 60%, rising to 80% in high secure settings (Menezes et 
al., 1996). Of 209 inpatients at a South East London regional secure unit, 37% met ICD-10 
criteria for DD. Poly-substance misuse was reported by 39% of the patient group (Isherwood 
& Brooke, 2001). 
 
Aetiology of Dual Disorder 
The „multiple risk factor model‟ (Smith & Hucker, 1994) attributes substance misuse 
among people with DD to a number of often related factors, in addition to those characteristic 
of the general population. According to the „self medication hypothesis‟ (Khantzian, 1985), 
people with mental health disorder use substances to counteract symptoms and side-effects 
from medication, albeit temporarily. Other risk factors include boredom, inactivity and 
impoverished life circumstances due to disadvantaged social, educational and vocational 
opportunities as well as cognitive deficits and poor interpersonal skills. As a marginalised 
group, involvement in the drug subculture can provide a sense of social connectedness. For 
some, being identified as a „drug user‟ is more acceptable and less stigmatising than a 
psychiatric label (Mueser, Bellack & Blanchard, 1992). 
 
Implications of Dual Disorder 
According to the „supersensitivity model‟ (Mueser, Drake & Wallach, 1998), people with 
mental health disorder are particularly susceptible to the adverse effects of psychoactive 
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substances, impacting not only the individual but also their family, their social network and 
the wider community. Within this population, substance use, even in moderation, is 
associated with: 1) earlier onset and exacerbation of mental health problems ; 2) lower levels 
of motivation to change; 3) comparatively poor engagement or non-compliance with 
treatment (Mueser, Drake, Turner & McGovern, 2006); 4) increased risk of relapse in mental 
state; 5) more frequent and longer hospital admissions (Drake, Mueser, Clark & Wallach, 
1996); 6) increased incidence of violence and suicide (Oyefeso, Ghodse, Clancy & Corkey, 
1999); 7) increased risk of blood borne disease; 8) increased risk of cardiovascular and 
respiratory disease and other medical conditions (Batki et al., 2009; Meade & Weiss, 2007); 
9) increased criminality and rates of imprisonment; 10) poorer social outcomes including 
breakdown in family relationships and homelessness (DoH, 2002). Compared with mental 
health service users generally, people with DD are more likely to be the victims of violence 
and sexual abuse (Lehman, Myers, Dixon & Johnson, 1994). 
 
Dual Disorder Services and Treatment Context 
As mentioned, there is poor collaboration between NHS mental health and substance 
misuse services, voluntary and private sector organisations working in this field, and the 
criminal justice system. As a result, people with DD are often bounced backwards and 
forwards between services, receiving inadequate if any input. As mentioned, when treatment 
is provided, it tends to be sequential across services or in parallel, neither of which have 
proven particularly effective (DoH, 2002). Compared with non-DD mental health service 
users, people with DD report higher levels of dissatisfaction with treatment and “perceived 
unmet need” (p. 283) which may dissuade them from returning to services in the future 
(Urbanoski, Cairney, Bassani & Rush, 2008). Other problems with services in this area 
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include insufficient resources and capacity and gaps in professional training specific to DD 
(DoH, 2002). 
 
Based primarily on research from the US, experts in the field now recognise the need for 
integrated approaches that treat co-existing mental health and substance use disorders 
simultaneously within a single service. The DoH (2002) Dual Diagnosis Good Practice Guide 
recommends mainstream mental health services take the lead in case-managing people with 
DD, involving specialist drug and alcohol teams where indicated. Parallel care, although not 
ideal, can be used as a make-way for integrated programmes. At the very least, which 
agencies are involved and in what capacity should be made explicit within a single 
overarching rather than separate policy. 
 
The Combined Psychosis and Substance Misuse (COMPASS) Programme (Graham et al., 
2003) is perhaps the most comprehensive integrated DD service in the UK. A shared protocol 
was put in place to coordinate treatment across existing mainstream and specialist mental 
health and substance misuse services. The aim is to address both disorders and their 
interaction effects as a whole, with “mainstream mental health clinicians” (Graham et al., 
2003, p. 184) taking the lead. Consultation and training is provided in DD assessment, 
motivational enhancement, cognitive therapy and relapse prevention. The Stages of Change 
(SoC) or transtheoretical model (TTM) espoused by Prochaska and DiClimente (1982) is 
used to match service users with the appropriate combination of treatments based on their 
„readiness to change‟. The accessibility of the programme is maximised through assertive 
outreach, involving interagency working and families. Once in treatment, a longitudinal 
perspective is taken where setbacks are seen as part of the recovery process (Bellack, 2007). 
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Whilst the outcomes of the COMPASS programme and other similar initiatives are 
promising, low treatment uptake, attrition and non-adherence remain common issues. More 
often than not, people with DD are either ambivalent about modifying their substance misuse 
or refuse altogether (Bellack, 2007). The National Institute of Drug Abuse (NIDA) invited 
1,777 people with co-occurring mental health and substance misuse disorders to engage in 
DD treatment not dissimilar to the COMPASS programme. Approximately half failed to 
attend the initial briefing and a further half dropped out during assessment. In total, 73% of 
the original sample did not take up treatment (Crits-Christoph, Siqueland, Blaine, Frank, 
Luborsky & Onken, 1999). Similar outcomes were reported by Bellack, Bennett, Gearon, 
Brown and Yang (2006). In this study, 46% of people with DD who consented to treatment 
failed to complete the initial assessment. 
 
Dual Disorder Treatment Uptake and Engagement: Barriers and Predictors 
Research has been carried out into factors that deter people with DD from accessing and 
engaging in treatment. According to Rassool (1998), possible barriers to DD treatment 
include: 1) stigma, 2) mistrust of healthcare professionals and fear of incrimination, 3) 
perceived unsuitability of treatments, 4) chaotic personal circumstances including debt, 5) 
psychiatric symptoms, particularly anxiety and depression, and 6) cognitive deficits. 
According to Williams (2002), it is not uncommon for healthcare professionals to hold 
negative attitudes towards people who misuse substances, perceiving them as „difficult to 
manage‟ which can be stigmatising (Weaver et al., 2003). Other service characteristics that 
are thought to impact attendance, therapeutic alliance and engagement in substance misuse 
and mental health services, even when motivation to change is high, include unwieldy 
referral processes and lengthy waiting lists (Cooper, Fairhurst, Hill, Ollerton & Roscoe, 
2006). 
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Until recently, minimal research had been carried out into the characteristics of people 
with DD that predict treatment uptake and engagement. Brown, Bennett, Li and Bellack 
(2011), found that men, people diagnosed with schizophrenia and people with an ongoing 
cocaine problem were significantly less likely to enter treatment. Recent arrest, 
comparatively high levels of drug dependency and perceived negative family relationships 
were inversely related to treatment engagement. In this study, motivation to change in 
accordance with the TTM was not shown to be related to either DD treatment initiation or 
engagement. However, by their own admission, Brown et al. (2011) acknowledged that the 
measures they used, albeit based on previous research, did not fully account for the 
complexities of individual people‟s lives and the nature of services as social operations 
involving human relationships. Inspired by the service user movement, Beresford (2006) 
argued that if clinicians and academics “do seek to undertake research and interpret service 
users knowledge and experience, then they must seek to get closer to it, in all its diversity” (p. 
168) through qualitative explorations of first hand experiences.  
 
Involving Service Users in Service Planning 
Over the last ten years, numerous local level and national agencies and documents have 
addressed the issue of uptake and engagement in mental health and substance misuse 
services. In the UK, seven national mental health organisations including service user groups 
came together to form the Future Vision Coalition (DoH, 2005) based on the recovery model, 
which is endorsed by National Institute for Mental Health in England (NIMHE, 2005). 
Amongst other things, this initiative emphasises the importance of involving service users in 
their care, encouraging them to take the lead in 1) identifying their treatment needs, 2) 
planning their care and 3) identifying their treatment goals. The concept of recovery in this 
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context is something service users define for themselves based on their own experiences and 
aspirations (e.g. Shepherd, Boardman & Slade, 2008). 
 
In 2001, the National Treatment Agency for Substance Misuse (NTA) came into existence 
with the remit to increase the accessibility of evidence based treatments for people who 
misuse substances. In 2005, NTA guidelines for „retaining clients in drug treatment‟ were 
published, outlining six broad recommendations. Like the above strategies, they highlight the 
benefits of having clients input into all aspects of service development, provision and 
management. The Audit Commission report, Drug Misuse 2004, stated “that to harness the 
potential to change behaviour, service providers must appreciate a user‟s own view of the 
future and allow informed choice and opportunity” (NTA, 2005, p. 18). To a degree, these 
developments are a reaction to traditional ways of working which attempt to fit service users 
to treatments rather than the other way round. In order to match people to the most 
appropriate treatment, it is increasingly recognized that it is important to understand their 
motivations for being there as they experience it (Drieschner, Lammers & van der Staak, 
2004), further building the argument for qualitative as well as quantitative research in this 
area 
 
Theories of Motivation 
Few scholars and clinicians would disagree that motivation plays an important role in 
“why and how individuals change health behaviours” (DiClemente, Nidecker & Bellack, 
2008, p. 26), affecting the uptake and utility of substance use treatments. The first widely 
accepted definition of treatment motivation is credited to Raskin (1961), who viewed it as a 
„traitlike‟ phenomenon. Experts in the substance use field such as Miller (1983) and 
Prochaska and DiClemente (1982) argued that this created a culture of blaming service users 
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for not engaging and progressing in treatment. According to Miller (1983) and the TTM, 
motivation for treatment is more accurately understood as part of a single dimensional change 
pathway which is responsive to multiple internal factors such as perceived need, sense of 
responsibility and commitment. It was suggested that these phenomena are fluid rather than 
fixed and that they are influenced by external variables, particularly interpersonal 
relationships. 
 
Understanding treatment motivation and motivation to change as interpersonal as well as 
intrapersonal heralded an important shift theoretically and clinically. In particular, it led to 
the development of motivational enhancement approaches, previously considered of no value 
(Bellack et al., 2006). Typically, these approaches incorporate motivational interviewing; a 
style of counselling partly derived from experimental psychology but far from mirroring it, 
applying concepts like attribution, cognitive dissonance and self-efficacy. According to this 
approach or theory, motivation is an interpersonal dynamic that therapists and service users 
work on collaboratively (Miller & Rollnick, 2002). 
 
The TTM provides an integrative framework for understanding, measuring and enhancing 
motivation for behaviour change. It is arguably the most predominant theory of motivation in 
not only addictions where it was developed, but preventive healthcare more generally 
(Prochaska, Redding & Evens, 2002). According to the literature supporting this model, the 
process of intentional behaviour change falls into five designations subdivided into two 
phases: „pre-action‟ followed by „action-oriented‟. The pre-action phase comprises the 
precontemplation (no intention to change), contemplation (thinking about change), and 
preparation (preparing to change) stages of change. The action-oriented phase comprises the 
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action (taking steps to change) and maintenance (actively maintaining change) stages of 
change (DiClemente & Prochaska, 1998). 
 
The TTM also addresses how people motivate, action and maintain behaviour change. Pre-
action tasks include “consciousness raising, self re-evaluation, environmental re-evaluation, 
and emotional arousal” (DiClemente et al., 2008, p. 26). Action-oriented tasks include “self-
liberation, stimulus control, counter conditioning, contingency management, and helping 
relationships” (DiClemente et al., 2008, p. 26). Assessing which change processes or tasks to 
target and selecting the appropriate intervention or combination of interventions is critical. 
Failure to do this can lead to poor treatment outcomes (Giovazolias & Davis, 2005; Miller & 
Rollnick, 2002). 
 
According to the TTM as applied to substance misuse disorder, non- or semi-directive 
interventions, usually motivational interviewing, are the treatment of choice for people in 
precontemplation, contemplation and preparation stages of change. Action oriented or 
directive approaches including traditional skills teaching, CBT and relapse prevention are 
recommended for people in the action or maintenance stage of change. Typically, individuals 
are assumed to move through the model or particular stages in the model multiple times 
before reaching maintenance (Miller & Rollnick, 2002).  Since its inception, several studies 
have supported the use of TTM within addictions, demonstrating consistent and reliable 
relationships between the processes and stages of change outlined (e.g. DiClemente & 
Prochaska, 1998). 
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Dual Disorder and Motivation 
To date, there has been relatively minimal research regarding motivation to change and 
treatment seeking motivation among people with DD. DiClemente et al. (2008) reviewed the 
literature in this area, most of which is based on the TTM. Their focus was on the 
conceptualisation and assessment of “readiness to modify substance use and readiness to 
initiate behaviours helpful for managing mental” (p. 25) disorder. As things stand, due to 
mixed findings, it cannot be assumed that the TTM, the conceptualisation of motivation 
underpinning it, and associated measures of „readiness to change‟ are directly transferable to 
DD groups. The same can be said about motivational enhancement theory and approaches 
such as motivational interviewing.  Haddock et al. (2003) found that motivational 
interviewing improves treatment outcomes for people with DD, especially when combined 
with CBT. However, a meta-analysis “of the efficacy of motivational interviewing in a dual 
diagnosis population” (p. 5417) by Osborn (2007) was inconclusive both in terms of 
treatment adherence and also substance use outcomes. 
 
Several studies have demonstrated a positive correlation between motivation to change, as 
defined by the TTM model, and attendance and engagement in treatment among non-dually 
disordered service users (Carpenter, Miele & Hasin, 2002). Using „readiness to change‟ 
measures based on the TTM, similar findings have been demonstrated with DD groups (e.g. 
Nidecker et al., 2009) but not consistently. Within the DD population, Pantalon and Swanson 
(2003) found lower, not higher, levels of motivation to change were predictive of treatment 
attendance. Similar outcomes have been reported by Zeidonis and Trudeau (1997) and 
Bellack et al. (2006). In their study of people with DD, Zeidonis and Trudeau (1997) found 
an inverse relationship between treatment seeking and motivation to change. According to 
Bellack et al. (2006), neither treatment attendance nor treatment adherence are associated 
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with readiness to change within this group. They argued that “these data cannot be discounted 
by questioning the ability of people with serious mental illness to provide reliable responses” 
(Bellack et al., 2006, p. 4) to the TTM measures that were used as has been suggested 
elsewhere in the literature (Strong, Kinnaman, Bellack, Brown & Yang, 2007).  
 
According to Heather (2005), the extent to which motivation plays a part in health 
behaviour change among people with DD and the mechanisms underpinning it are different 
to that characteristic of non-dually disordered service users. Finnell (2003) suggests that DD 
and non-DD service users differ in how they move from pre-action to action-oriented phases 
of the TTM. In contrast with non-DD substance misuse service users, people with DD 
employ „action‟ or behavioural mechanisms for change when their motivation is low and 
„pre-action‟ or experiential mechanisms for change when their motivation is high, which has 
implications for treatment matching. Best practice guidelines for treating substance misuse 
disorder recommend taking a non-directive approach when motivation to change is low. This 
gives way to more directive interventions as intrinsic motivation for behaviour change 
increases (DoH, 2002). For people with DD, the opposite combination of treatments might be 
more appropriate (DiClemente et al., 2008). A possible explanation for this is that cognitive 
deficits associated with severe forms of mental disorder interfere with the processes thought 
to be important for motivating behaviour change such as decision making, goal setting, 
problem solving, concentration and perseverance. 
 
According to the Centre for Substance Abuse Treatment (2005), the greater the severity of 
mental disorder the less likely the individual is to view their substance misuse as problematic. 
It is suggested that reduced capacity for self-appraisal along with so called negative 
symptoms of mental disorder such as avolition mitigate motivation to change, treatment 
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uptake and treatment engagement. Also, it is not uncommon for people with DD to be 
motivated to address their substance misuse or their mental health disorder but not both 
(Heesch, Velasquez & Sternberg, 2005). This has led people to speculate that each disorder 
has its own separate underlying motivational and behavioural change processes (DiClemente 
et al., 2008). 
 
Consistent with Osborn‟s (2007) meta-analysis mentioned earlier, motivational 
enhancement theory and approaches to increase uptake and engagement in treatments may 
not benefit people with DD in the same way they benefit substance misuse and other service 
user populations for whom they have been evaluated (Finnell, 2003). Within the addictions 
field, the goal of motivational enhancement approaches in the early stages is to build intrinsic 
motivation for change, considered pivotal in overcoming substance misuse in the long term. 
For people with DD, interventions that target external determinants of motivation such as 
contingency management might have greater utility. Contingency management is 
recommended by the National Institute for Health and Clinical Excellence (NICE, 2007) for 
people who are dependent on opiates or stimulants, reinforcing positive behaviours and 
treatment adherence with incentives such as vouchers. Messina, Farabee and Rawson (2003) 
argued that rewards based rather than „punitive‟ approaches might be particularly useful for 
people with co-occurring personality difficulties.  A problem with all of these interventions, 
however, is that they only benefit people who are already engaged in services, failing to 
address the problem of treatment uptake. 
 
Criticisms of the Transtheoretical Model 
Despite capturing the interests of researchers since the 1950s, motivation and its 
relationship with treatment uptake and engagement remain conceptually ambiguous (West, 
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2006; Sutton, 2001).  Sutton (2001) ascribes this lack of clarity to the dominance of the TTM 
which he, along with other luminaries in the field, believes is fundamentally flawed. 
According to Sutton (2001), defining motivation as the likelihood an individual will seek out 
and engage in a particular course of action is circular, leading clinicians and researchers to 
think of motivation to change and treatment motivation as synonymous. 
 
Typically, human motivation is conceptualised in terms of the internal mechanisms 
driving a particular behaviour. According to Bellack et al. (2006), the TTM fails to 
adequately delineate these phenomena. Because of this, treatment motivation is often defined 
incorrectly by the forces affecting it such as a desire or wish to change. That is, people who 
want to change are by implication motivated to change which, as mentioned, is often not the 
case. Even when treatment motivation is linked to a resulting behaviour there is conceptual 
ambiguity. Sometimes the behaviour is defined as the act of entering treatment, whilst at 
other times it is defined as the act of engaging in the treatment process. Another criticism of 
the TTM and allied theories such as motivational interviewing is that they over emphasise the 
significance of „problem recognition‟ at the expense of other “factors such as perceived 
external pressure, outcome expectancies, or the perceived suitability of treatment” 
(Drieschner et al., 2004, p. 1123). 
 
A further criticism of the TTM is the notion that people move sequentially through five 
stages of change from precontemplation to maintenance. Sutton (2001) and West (2006) 
argue that these stages are not mutually distinct which makes it difficult to assess movement 
from one to another or to gauge fluctuations in motivation through time. Research indicates 
that the five stages of the TTM would be better conceptualised as two separate components: 
“cognitive determinants of treatment motivation” (Drieschner et al., 2004, p. 1123) and 2) 
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“behaviour that depends on the level of treatment motivation” (Drieschner et al., 2004, p. 
1123). 
 
Recent Developments in Motivational Theory 
Attempts have been made in the last few years to address the ambiguities regarding 
treatment motivation highlighted above. Based on research into smoking cessation, PRIME 
Theory of Motivation (West, 2006) posits that human behaviour is driven by: plans, 
responses, impulses or inhibitions, motives and evaluations. Drieschner et al‟s. (2004) 
„integral conceptualisation of treatment motivation‟ suggests: 1) external motivators are 
mediated by internal mechanisms; 2) „motivation to engage in treatment‟ is based on „internal 
determinants‟ of which there are six; 3) „motivation to engage in treatment‟ is predictive of 
„treatment engagement‟; 4) „treatment engagement‟ is predictive of „treatment outcome‟.  As 
yet, to the author‟s knowledge, neither model has been evaluated within the DD population or 
addictions generally, with the exception of tobacco dependency, to see if it is a more useful 
alternative to the TTM. 
 
Drieschner et al. (2004) argued that the exact nature of treatment motivation and related 
concepts differs depending not only on the client group under consideration but also the 
treatment approach being used. It is suggested models and measures of treatment motivation 
are adapted to account for these differences. The TTM seems to have had success in being 
applied to understand treatment motivation with a number of addictions and, more recently, 
mental health disorders (Jerkovic, 2007). However, in some quarters, the theory underpinning 
the TTM has been questioned. One problem is that it relates to „readiness to change‟ which is 
not necessarily the same as motivation to enter and engage in treatment. To date, it appears 
that no models of motivation have been modified specifically for DD and then evaluated to 
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assess their utility for these service users in relation to difficulties with treatment uptake and 
engagement and how they might be overcome. 
 
Summary 
Dual disorder represents a considerable challenge for adult mental health and substance 
misuse services. As many as three in four people referred to adult mental health and 
substance misuse services suffer from DD, the implications of which include poorer mental, 
physical and social outcomes. To meet this challenge, health authorities up and down the UK 
are commissioning integrative DD treatment programmes based in mental health services. 
Once in treatment, the prognosis for people with DD is encouraging (Carey, Leontieva, 
Maisto & Batki, 2006). However, low rate of treatment uptake and dropout from treatment 
remains a concern (Mueser, Noordsey, Drake & Fox, 2003). 
 
To address these issues, it is important to understand what motivates people with DD to 
enter and then engage in treatment. A criticism of the literature in this area is that, due to an 
over reliance on the TTM, motivation to change and treatment motivation are often seen as 
one and the same thing. As mentioned, among people with DD, attendance at treatment has 
not been shown consistently to correlate with „readiness to change‟ (e.g. Bellack et al., 2006). 
By the same token, perhaps surprisingly, non-engagement in DD treatment is seen even in 
people with apparently high levels of motivation to change. This highlights that there is a 
difference between motivation to change, and treatment motivation, and it is suggested here 
that it is helpful to retain a distinction between these two motivations, although they are often 
closely related.  
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Also, it is suggested that motivation for treatment and change among people with DD is 
qualitatively different from motivation for treatment and change among singly disordered 
substance misuse service users (e.g. Bellack et al., 2006). The implications of this are that 
motivation measures and interventions developed in the addictions field, based 
predominantly on the TTM, might not be applicable to DD groups, clinically or for the 
purposes of research. Within the DD field, some service users seek treatment to address their 
mental health but not their substance misuse. Others may not accept their mental health 
diagnosis but want to stop substance misuse (Heesch et al., 2005). It is thought that both 
disorders and their interaction effects impact whether or not an individual takes up and 
engages in treatment. Understanding the motivational features and levels of each area of 
difficulty would seem important in order to provide the appropriate treatments (DiClemente 
et al., 2008). 
 
Despite increasing interest in recent years, our understanding of how motivation relates 
specifically to people with DD remains limited. In part, this is due to the lack of clarity 
surrounding motivational theory generally. In particular, further research is needed to 
conceptually distinguish between treatment seeking motivation and motivation for change 
and how these interact among people with DD relative to other treatment contexts. This 
would inform the development of suitable measures for assessing DD treatment motivation 
and engagement. It might also lead to the adaptation and integration of more accessible and 
effective interventions for people with DD, enabling not only clinicians but also service 
mangers and providers to help people with DD address their multi-complex and overlapping 
problems (DiClemente et al., 2008). 
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The Need for Qualitative Research 
Due to the lack of evidence base and clarity in the area, it is argued that qualitative studies 
involving in-depth interviews with service users and clinicians are needed to explore DD 
treatment motivation, the forces underlying it, and its relationship with treatment 
engagement. Drieschner et al. (2004) suggest that client self-report is “the most appropriate 
mode of assessment for the internal and subjective concepts” (p. 1131) of treatment 
motivation while clinicians might offer important insights into the observable aspects of 
treatment engagement (Schmidt & Woolaway-Bickel, 2000). Gauging the views of both 
clinicians and service users on these issues would be within the spirit of the Future Vision 
Coalition (DoH, 2005), NIMHE (2005) and NTA (2005) initiatives that seek to improve the 
accessibility and effectiveness of services for people with mental health and substance use 
disorder.  
 
Numerous qualitative research studies have been carried out in the addiction field, 
contributing significantly to the literature in that area. One approach that has been particularly 
illustrative of how people change or recover from substance use problems is narrative 
analysis (e.g Hanninen & Koski-Jannes, 1999). To the author‟s knowledge, narrative analysis 
has not yet been used with DD service users. It is envisaged stories elicited from service users 
and clinicians, illustrating the points at which treatment motivation seems to change or 
engagement increases or decreases for specific individuals, could have implications for 
developing interventions to increase firstly the accessibility of DD services and treatments, 
and secondly retention rates of clients already engaged with services. Such a study could 
explore what appear to be the determinants of DD treatment motivation and its relationship 
with DD treatment engagement and how their interactions are experienced as unfolding over 
time in response to both individual and service related contingencies. 
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Abstract 
Rationale. There is an emerging evidence base to support the use of integrated approaches 
that treat co-existing mental health and substance use disorder simultaneously. However, low 
rates of treatment uptake and engagement remain a concern. To address this, it would seem 
important to understand dual diagnosis treatment motivation and engagement, an area that 
has received little attention from the research community. Aims. The aim of this study was to 
explore service user‟ and clinician' understandings of how treatment motivation and its 
relationship with treatment engagement relate specifically to people with dual diagnosis. 
Methodology. Transcripts from semi-structured interviews with four service users and four 
clinicians were analysed using narrative methodology. Findings. The current study suggests 
that the factors underpinning treatment motivation and engagement among people viewed as 
having dual diagnosis are similar to those thought to be associated with addictions and mental 
health disorders generally although their relative influence and interaction effect might be 
different. It is suggested that negative perceptions of services, difficulties with trust, and 
therapeutic relationship are particularly important issues among dual diagnosis populations. 
Discussion. Clinical and theoretical implications of the study are discussed in relation to the 
literature as well as recommendations for future research. 
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Introduction 
Dual Diagnosis 
Dual diagnosis is arguably the single most challenging issue facing adult mental health 
services (Department of Health, 2002). In theory, it can encompass multiple permutations of 
mental and personality disorder co-existing with various types and levels of single or poly 
substance use. In practice, teasing apart the relative impact of these problems and their 
interaction effects can prove difficult. Also, the term diagnosis is not without problems as it 
runs the risk of pathologising complex life issues (Bentall, 2005). In this study, the term dual 
disorder (DD) will be used. 
 
Prevalence and Implications of Dual Disorder 
The life time prevalence of substance misuse among people with major mental disorder is 
between 15% and 60% (Menezes et al., 1996).  Within this population, substance use, even in 
moderation, can have major detrimental effects (DoH, 2002) including poor compliance with 
treatment (Mueser, Drake, Turner & McGovern, 2006), increased risk of medical conditions, 
and poorer social outcomes and interpersonal difficulties (Batki et al. 2009; Meade & Weiss, 
2007). 
 
Treatment for Dual Disorder 
Traditionally, there has been poor collaboration between adult mental health and addiction 
services. As a result, people with DD are often bounced backwards and forwards between 
services. At best, treatment is provided sequentially across services or in parallel, neither of 
which have proven particularly effective (DoH, 2002). Other reported problems include 
insufficient resources and capacity, gaps in professional training specific to DD and high 
levels of staff burnout (DiClemente, Nidecker & Bellack, 2008). 
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To address these problems, experts in the field now support integrated treatment 
approaches within a single service that address a range of biopsychosocial factors 
simultaneously, not just mental health and substance misuse issues (Jeffrey, Ley, Bennum & 
McLaren, 2000). Typically, Prochaska and DiClemente‟s (1982) transtheoretical model 
(TTM) is used to match service users to the appropriate combination of treatment approaches 
based on their „readiness to change‟. In the UK, the COMPASS Programme (Graham et al., 
2003) is perhaps the most comprehensive initiative of this kind. Whilst the outcomes of this 
and other similar programmes is promising, low treatment uptake, attrition and non-
adherence remain common issues (Bellack, 2007; Mueser, Noordsy, Drake & Fox, 2003). 
Given the emerging evidence base for DD services, more needs to be done to increase 
treatment motivation within this population (Bellack, 2007). 
 
Theories of Motivation 
Over the past 20 years, the TTM has been the predominant theory of motivation, 
particularly in the addictions field. Based on this model, Miller and Rollnick (2002) defined 
motivation as the likelihood a person will adopt and follow a particular pathway for change. 
According to this definition, treatment motivation is thought to comprise part of a single 
dimensional change pathway. In research and clinically, this has led people to think of 
motivation to change and treatment motivation as synonymous which has been criticised as 
circular (Sutton, 2001). 
 
Also, attendance at DD treatment does not correlate with „readiness to change‟ (e.g. 
Bellack, 2007). Perhaps surprisingly, non-engagement in DD treatment is seen even in people 
with apparently high levels of motivation to change. Others enter into DD treatment but are 
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not motivated to change their substance misuse (Heesch, Velasquez & von Sternberg, 2005). 
This highlights that there is a difference between the more generic concept of motivation to 
change and treatment motivation. Although closely related, it is suggested here that it is 
helpful to retain a distinction between these two motivations. 
 
Typically, human motivation is conceptualised in terms of the internal mechanisms 
driving a particular behaviour. According to Bellack (2007), the TTM fails to adequately 
delineate these phenomena. Because of this, treatment motivation is often defined by the 
forces affecting it such as a desire for change. Even when treatment motivation is linked to a 
resulting behaviour there is conceptual ambiguity (Drieschner, Lammers & van der Staak, 
2004). Sometimes it is defined as the act of entering treatment whilst at other times it is 
defined in terms of treatment engagement. A further criticism of TTM is the notion that 
people move sequentially through five stages of change. Sutton (2001) argued that these 
stages are not mutually distinct which makes it difficult to assess movement from one to 
another or to gauge fluctuations in motivation through time and in different contexts. 
 
Drieschner et al.‟s (2004) „integral conceptualisation of treatment motivation‟ addresses 
the lack of conceptual clarity highlighted. It suggests treatment motivation and engagement 
are based on „internal determinants‟ of which there are six: „level of suffering‟, „outcome 
expectancy‟, „problem recognition‟, „perceived suitability of the treatment‟, „perceived cost 
of the treatment‟ and „perceived external pressure‟. According to Drieschner et al. (2004), the 
exact nature of treatment motivation and related concepts differs depending on the population 
under consideration. It is suggested models and measures of treatment motivation are adapted 
to account for these differences. The TTM was an attempt to understand the mechanisms and 
processes of behaviour change relating to addictions. Subsequently, it has been applied to 
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other clinical fields including DD (e.g. DiClemente et al., 2008). To date, no models of 
motivation have been evaluated and adapted specifically to explain DD treatment uptake and 
engagement. To explore these issues, it would seem important to gather a small number of in-
depth accounts from DD service users and people who work in the field. 
 
Summary and Study Rationale 
Dual disorder represents a considerable challenge for mental health services. To meet this 
challenge, health authorities are commissioning integrative DD treatment programmes. Once 
in treatment, outcomes for people with DD are encouraging (Carey, Leontieva, Dimmock, 
Maisto & Batki, 2007). However, levels of treatment uptake are low (Bellack, 2007; Mueser 
et al., 2003). To address this, it is important to understand what motivates people with DD to 
enter treatment. In this regard, it cannot be assumed that treatment motivation and motivation 
to engage in treatment, although related, are one and the same thing. 
 
To date, minimal research has been carried out into the factors and processes underlying 
treatment motivation and its relationship with treatment engagement among people with DD. 
Studies of DD motivation more generally have relied on the TTM and associated measures 
which have been criticised in the literature as conceptually ambiguous. To the author‟s 
knowledge, no research has been carried out into the meanings service users and clinicians 
make of DD treatment motivation and engagement. It is envisaged the information provided 
by participants will have implications for developing interventions to increase 1) the 
accessibility and uptake of DD services and treatments, and 2) retention rates of people 
already engaged in DD services and treatments. 
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Aim of Study 
The aim of the study was to gain insights into the „stories‟ service users and clinicians tell 
about DD treatment motivation. This gathering of narratives or „stories‟ (Riessman, 2008) 
would provide a starting point for examining the complexities of motivation and treatment 
entry and engagement in the context of DD. 
 
Specific Research Questions 
The current study was guided by the following questions: 
1. What determinants of motivation to enter DD treatment feature in the stories of 
service users and clinicians? 
2. What stories do DD service users and clinicians tell about how motivation for 
treatment fluctuates over time? 
3. What connections do people make in their stories between DD treatment motivation 
and DD treatment engagement? 
 
Method 
Participants 
Through „purposive‟ sampling (Marshall, 1996), the study recruited eight participants 
from Community Adult Mental Health Teams (CMHTs) and Community Drug and Alcohol 
Teams (CDATs): four service users with DD and four clinicians with experience working 
with DD and DD treatments. Narrative analysis, the current methodology, is a case rather 
than category-centred or population based form of inquiry (Riessman, 2008). As such, sample 
size and configuration tends to be based on theoretical or opportunistic grounds (Squire, 
2008). Within healthcare, it has been used with as few as one or two participants (Bell, 1988; 
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Lee & Bonnie, 2006; Lee, 2001). On this basis, the current sample size of eight was 
considered sufficient to provide usable data to address the research questions. 
 
As a case-centred approach, narrative analysis is not concerned with generic concepts. 
However, it can be used to make inferences about the wider population and social processes, 
illuminating variations across people and contexts (Riessman, 2008). With this is mind, 
interviews were carried out with both DD service users and DD clinicians. This was based on 
the idea that treatment motivation is an interpersonal construct, influenced by not only the 
service user but also the treatment context (Miller & Rollnick, 2002). Another reason for 
interviewing both service users and clinicians relates to the current emphasis on involving 
different stake holders in the evaluation and development of mental health treatments (e.g. 
NIMHE, 2005). Guided by the research questions, the following inclusion and exclusion 
criteria were applied: 
 
Service user inclusion criteria: 
a) DD acknowledged as present by both service user and clinicians with or without a 
formal diagnosis. 
b) Receiving treatment for mental health and substance use within the NHS Trust 
c) Authorization by the responsible NHS Team 
d) Sufficient command of English to engage in the data collection process 
e) Capacity to consent 
 
 Clinician inclusion criteria: 
a) Any CMHT or CDAT clinician with experience working with DD. 
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Exclusion criteria: 
a) Service users were excluded from the study if they were assessed by their care team 
or the researcher as representing a risk to themselves or others. 
 
Clinicians involved in the study included three females and one male. With regards to 
ethnicity, two were Black African and two were White British. All had at least 10 years 
experience working with DD clients. Table 1 provides information about their work setting 
and job title. 
 
Table 1: Clinicians  
Pseudonym Work setting Job title 
Susan CMHT DD service link worker 
Jane CMHT Social worker 
Isabel CMHT (Assertive 
outreach) 
Team leader 
Sid CDAT Team leader 
 
Three service users involved in the study were male and one was female with an age range 
of 35 to 57 years. One was Black Caribbean and three were White British. Table 2 provides 
information about their mental disorder, substance use and current treatment.  
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Table 2: Service users 
Pseudonym Mental disorder Main substance use Current 
treatment 
Tracey Borderline 
PD/Depression 
Opiates/Cocaine/Alcohol CDAT 
Anne Depression/Panic 
attacks 
Alcohol/Non-prescribed 
meds 
CDAT 
John Borderline PD/ 
Anxiety/Depression 
Opiates/Cocaine/Alcohol CDAT 
Bill Anxiety/Panic 
attacks/Depression 
Opiates/Stimulants CDAT 
 
Ethics 
The study was approved by an Independent Research Review at Canterbury Christ Church 
University, National Research Ethics Service (see Appendix A) and NHS Foundation Trust 
Research and Development (see Appendix B). Prior to interviews, participants were required 
to read and sign a consent form (see Appendix C). 
 
Design 
Due to the lack of research in this area, a qualitative design was thought to be 
appropriate to gain a richness of data that would not be accessible using variable-based 
quantitative methods. From a social constructivist perspective, narrative analysis of stories 
was used to highlight personal sense-making and to preserve the way people do this in their 
recounting of the complexity of interactions between motivation and their experiences of 
different elements of DD treatment and services, taking into account reciprocal relationships 
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and wider social influences. According to Bruner (1990), people make sense of and describe 
the consequential interrelationships between events and ideas through narratives or stories. 
 
Narrative analysis was chosen as opposed to other qualitative methodologies such as 
Interpretive Phenomenological Analysis, Grounded Theory and purely discursive approaches 
for three reasons. First, through focussing on whole stories, narrative analysis does not reduce 
individuals‟ experiences down into smaller parts or categories that become separated from 
their context. According to proponents of this approach, identifying and preserving stories as 
a form of analysis illustrates more naturalistically the meaning of events for participants (e.g. 
Riessman, 2008). Second, it seemed important to investigate not only the content of 
participant‟s stories but also how and why they were told in relation to the interview context 
and wider theoretical and social discourses. Third, while useful for developing population 
based models or generic concepts, category-centred methods, such as Grounded Theory, lose 
the sequence of events or actions embedded in personal histories, a defining characteristic of 
narrative (e.g. Riessman, 2008). This emphasis on sequential or temporal features seemed 
important to capture how participants‟ experiences of DD treatment motivation and 
engagement, and the interrelationship between the two, shifted and transformed through time. 
 
Interview Schedules 
Interview schedules (see Appendix D and E) were constructed, inviting participants to tell 
stories about particular times and experiences in their life concerning the research questions. 
They were piloted on colleagues to rehearse technique and to iron out problems with format. 
Further modifications were made based on feedback from the study lead supervisor. 
 
 
40 
Running Head: Dual Diagnosis Treatment Motivation 
Procedure 
Clinicians were recruited through CMHT and CDAT meetings. Care coordinators were 
asked to distribute the „participant information sheet‟ (see Appendix F) to service users who 
met the inclusion criteria. It was also possible to volunteer for the study by responding to 
leaflets (see Appendix G) posted in clinic waiting rooms. Interviews were at the clinic where 
participants worked or received treatment. 
 
Data Analysis and Quality Issues 
Although there are different interpretations of narrative methodology, generally they share 
the view that narrative is about sequences of events or causal relationships unfolding in time 
(Riessman, 2008). The current study “privileged respondents‟ views, responses, voice, 
experience and meaning-making” (Murray, 2003, p. 50) in relation to the topic under 
investigation, taking into account the researcher‟s role in co-constructing narratives and the 
influence of broader theoretical and social discourses. 
 
The analysis was carried out in five stages beginning with the transcription of audio-
recordings (see Appendix H). Transcripts captured not only the content of what participants 
said but also non-lexical features such as pauses and repetitions which, according to the 
literature, indicate “why a story is worth telling” (Bell, 1988, p. 109). Non-verbal 
communications were excluded. Initial thoughts about participants‟ stories based on 
preliminary readings of whole transcripts were recorded (see Appendix I). 
 
In stage two, core narratives relating to the topic of investigation were defined and 
extracted from transcripts based on structural features using Labov‟s (1982) method (see 
Appendix J). Clauses within core narratives were grouped into the following categories based 
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on their function: 1) summary of the narrative (abstract); 2) contextual factors such as time 
and place (orientation); 3) salient points, themes, characters and plots (complicating event); 
4) the narrator's view or interpretation (evaluation); 5) endings (resolution); 6) how the 
narrator was reoriented in the present (coda). Applying this method, stories were defined as 
“a brief, bounded segment of interview text, rather than an extended biographical account” 
(Riessman, 2008, p. 61). In stage three, core narratives thought to be most relevant to the 
research questions were selected (see Appendix K) and interpreted in relation to these 
questions (see Appendix L). In particular, the focus was on „complicating events‟ and 
„evaluations‟. 
 
Riessman (1993) argues that reducing transcripts down to “core narratives, although useful 
initially, excludes important features that are essential to a fuller interpretation” (p. 38). In 
stage four of the analysis, like Bell (1999), the current study expanded on Labov‟s (1982) 
method to include “reciprocal actions” (Riessman, 1993, p. 41) of participants and researcher. 
For this purpose, the researcher‟s questions, prompts and utterances were considered. Close 
attention was paid to how participants positioned the researcher in relation to their stories, 
taking into account issues such as gender and professional status (see Appendix M). In stage 
five of the analysis, thematic links (Polkinghorne, 1995) were made between participants‟ 
core narratives previously grouped under the research questions in stage three of the analysis 
(see Appendix N).  
 
Steps taken to maximise the rigour and quality of the analysis were based on Elliot‟s 
(2006) „common sense‟ approach and Mishler‟s (1990) notion of „trustworthiness‟. With 
regards to independent validation, the research lead supervisor provided feedback on each 
stage of the analysis for one service user and one clinician. Following interviews, for 
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respondent validation, participants were given a written summary of their stories (see 
Appendix O) and invited to feedback whether or not they reflected what they wanted to 
convey (see Appendix P). 
 
Results 
There are two parts to the results section. First, excerpts from stories are reported to 
illustrate the themes identified in stage five of the analysis, providing “explanatory answers to 
the research questions” (Polkinghorne, 1995, p. 15). Second, one service user (Anne) and one 
clinician (Susan) are reported to illustrate how language was used in the telling of stories and 
the role of the researcher in co-constructing narratives. 
 
What Determinants of Motivation to Enter DD Treatment Featured in the Stories of 
Service Users and Clinicians? 
This question seemed to be addressed by stories relating to the following themes: 1) life 
events, both positive and negative, that had personal significance, 2) a wish for things to 
change and 3) negative perceptions of services. 
 
Stories about significant life events. 
Participants told 16 stories associated with this theme. The events referred to included 
pregnancy, new „loving‟ relationship, family ultimatum, medical problems, near death 
experience, bereavement and “hitting rock bottom”. 
 
„The Power of Love‟, a story by Susan (clinician), highlighted how a new „loving‟ 
relationship can elicit treatment motivation: “They [service users] finally find someone that 
paid them attention and loved them like they had never been loved before.” In his story, „Do 
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It For Me [Girlfriend] and Do It For The Girls‟, John (service user) recalled an ultimatum 
from his then girlfriend that gave him the impetus he needed to initiate treatment:  
 
“I come home one night stinking of it [heroin] and she [ex-partner] went “you‟re back on 
that shit again aren‟t you?” And I went “yeah”, she went straight to bed and I fell asleep 
on the settee, [ ... ] then she came downstairs, she‟s got a hold-all packed, she went 
“where do you want dropping off?” and I went “well what do you mean” and she went 
“go”, she went “I‟ve had it” she went “sixteen years I‟ve put up with it. I can‟t put up 
with it no more”. 
 
According to clinicians‟ stories, some people are unmotivated to access services and 
treatment until they “hit rock bottom” or until matters are taken out of their hands. This was 
illustrated in the following excerpt from Sid‟s (clinician) story „Most Are in a Desperate 
Situation When They Access Services‟: 
 
“I think they more or less lurch around until they go into various states of depression and 
either pitch up in treatment that, um, looking for help, or, um, it‟s picked up somewhere 
along the line either through the Criminal Justice System or, or the mental health services. 
[ ... ] Most people, by the time they‟ve reached somebody like me are in a desperate 
situation”. 
 
Stories about a wish for change. 
The stories linked to this theme, 10 in total, were about people being motivated to access 
treatment and address their problems due to pride, unfulfilled ambitions, family relationships 
or a desire for a happier and less chaotic life. 
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Susan‟s (clinician) story, „The Power of Pride‟, described a woman who was resistant to 
addressing her drinking problem despite serious medical concerns. In the end it was the 
prospect of going into care and losing her home, which she was “proud of”,  that seemed to 
be the tipping point that elicited treatment motivation. In a separate but overlapping story, 
„To Realise a Dream‟, Susan described a service user who came to a point in his life where he 
wanted to fulfil hopes and ambitions he had prior to his mental health and substance use 
disorders: 
 
“I had a guy [service user] who had been smoking cannabis since nine years old and felt 
look “I am not getting any younger, I am in my mid forties, I need to do something with my 
life, I want to write a book, this [cannabis] affects me”. Their own future dreams and 
ambitions.” 
 
„I Wanted Help Because My Children Need Me‟, a story by Tracey (service user), 
highlighted how sense of responsibility and preferred identity as a mother helped her turn a 
corner. She said:  
 
“I am important for my children, you know. I changed the way I was thinking, you know. 
Before I didn‟t matter, but now I suddenly became important; yes I do matter, I matter for 
my children so I need to be alright for them to be alright.” 
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Stories about negative perceptions of services.  
The majority of the stories in this theme, 38 in total, were about perceived failings within 
services. Stigma associated with mental health and addictions clinics and its affect on 
treatment motivation was also highlighted. 
 
Anne (service user) repeatedly asked for help from services without success. When they 
did eventually take up her case, she felt ignored, silenced or disbelieved. As a result, she had 
difficulty trusting services. Tracey‟s story, „I Only Got to See a Psychiatrist When I Was 
Really Ill‟, criticised services for not intervening until she was in crisis. Like Anne and 
Tracey, John “knew something was wrong”. He said he “begged for help” from “doctors” 
but they “did not listen”, telling him his preoccupation with being “ill” was actually making 
him “worse”. In several connected stories, he said he was neglected and victimised by 
services and professionals. The following excerpt is from „I Had to Fight to Be Believed‟: 
 
“he [psychiatrist] said “er, you haven‟t had a fit this week”, I went “I have”, I said “I‟ve 
had at least four a day”. And he went “well there isn‟t anything in the book [clinical 
record]” [ ... ] and he went [to the nurses] “well, why isn‟t it put down there [in the 
clinical record]” “Well John never told us”. And, like, they [nurses] were blatantly lying, 
calling me a liar.” 
 
Isabel (clinician), in her account, argued that “mentally ill” labels can be a “sort of 
bugbear [for people and] something they can do without”. According to Sid, the physical 
appearance of CDATs can be a problem, stigmatising those who access them. The following 
is an excerpt from his story „Physical Environment of Clinics‟: “bulletproof glass, you know, 
air locks etc etc, er, a particularly fetching burnt front door, um, that we‟ve got at the 
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moment.[ ... ] If you‟re seen walking through here [Addictions Service] you might as well be 
wearing a sign.” 
 
What Stories do DD Service Users and Clinicians Tell About How Motivation for 
Treatment Fluctuates Over Time? 
The stories thought to provide answers to this research question were subdivided into two 
themes. The first theme highlighted conflicting variables that had a destabilising effect on 
treatment motivation. The second theme was about how treatment motivation can ebb and 
flow in response to services. 
 
Stories about opposite pulls. 
Nine stories were thought to relate to this theme. According to these stories, levels of 
treatment motivation can be pulled in different directions by family pressures, chaotic life 
circumstances, pressures of parenthood, „drug identity‟ and social networks, „cravings‟ and 
unstable mental health conditions. 
 
The following excerpt from Isabel‟s story, „Disagreements Within Families‟, describes a 
service user with conflicted feelings about treatment due to differences of opinion between 
his parents:  
 
“when one member of the parents [ ... ] hold[s] one view and then another member holds 
another view, then the client is in the middle, and often times we find that dad will be 
saying something, everything quite negative [ ... ]  whereas maybe mum will be the one, 
you know, be positive and working with you [services].” 
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Tracey‟s story, „I Would Dwindle In and Out of Services‟, referred to her desire to regain 
custody of her children which was motivational one minute and destabilising the next. As 
such, for several years, she oscillated between her „drug life‟ and services, “never really 
taking it in”. Anne also had an ambivalent relationship with substances. On the one hand, she 
“never liked” „drugs‟ and recognised the consequences. On the other hand, she relied on them 
as a means of coping. Also, they were important to her sense of identity and relationships as 
following excerpt from „I Still Miss it Sometimes‟ illustrates: 
 
“I needed to be liked at one point as well so I would go around buying drink and drugs 
then, you know, everybody would come to me, and I, that was like my own buzz as well as 
taking the drugs, you know”. 
 
John was in two minds about accessing his current CDAT. He felt the service had “looked 
down [their] nose” at him on a previous occasion. At the same time, he was under pressure 
from his partner to address his difficulties. This dilemma is illustrated in the following 
excerpt from „The People Here [Specialist Addictions] Sat and Listened to Me‟:  
 
“and I stood outside for a week, just stood outside looking up [ ... ] at this building 
[CDAT]  thinking do I go in there and get looked down my nose at and get abused or do I 
stay here, do I stay on the gear?”. 
 
Stories about the ebb and flow of treatment motivation in response to services. 
The stories in this theme, 10 in total, emphasised the importance of having accessible 
treatments that are appropriate to the needs and expectations of service users. In her story, 
„The Right Treatment at the Right Time‟, Susan described a service user who “went back to 
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square one” due to the inability of services to provide the treatment he believed he needed 
within an acceptable timeframe:  
 
“Often when we get people [service users] that started off very motivated and wanting to 
do it [treatment] , the kind of service sometimes puts them off. [ ... ]  They want to go to [a]  
„detox‟ unit, but actually there is a seven month waiting list.” 
 
It is typical for people to see whichever team member is available for a period when they 
first enter services. According to stories from Sid and Tracey, this can be unhelpful. In 
„Service Users Want Consistency in Their Relationships with Professionals‟, Sid argued: 
“you need to be consistent, and that‟s another thing that in my experience clients want. You 
need to be around, so they [service users]  don‟t like being passed from pillar to post”. 
 
What Connections do People Make in Their Stories Between DD Treatment Motivation 
and DD Treatment Engagement? 
Stories that seemed to address this question were about 1) individual factors that inhibit 
engagement, 2) negative perceptions of services, 3) the role of services in promoting 
engagement and 4) how progress in treatment reinforces engagement.  
 
Stories about individual factors that inhibit engagement. 
 Participants told 11 stories that were thought to fall into this theme, highlighting issues such 
as mental capacity, unrealistic expectations, difficulties with trust, reliance on „drugs‟ and 
„drug identity‟. Susan and Jane told stories about service users who have difficulties engaging 
in treatments due to impaired „mental capacity‟. In „Mental Capacity to Engage‟, Jane 
(clinician) said: “To be honest his [service user]  mental illness impacts a lot on his capacity 
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to cope with any traditional drug treatment [ ... ]. He can‟t sit and hold a conversation for 
longer than about 15 minutes”. 
 
According to stories from Jane and Isabel, some service users are motivated to address 
their mental health problems but not their substance use, suggesting a lack of awareness of 
the interaction effects of the dual disorders and wider social difficulties. According to Susan‟s 
account, it can be difficult for people to give up something they enjoy or have come to rely 
on as an “emotional crutch”. Over time this reliance on „drugs‟ can become an integral part 
of the person‟s identity and social networks. As Isabel put it “what else is there”. 
 
Stories about negative perceptions of services.  
The majority of stories in this theme, 10 in total, were about past unhelpful experiences of 
services and their impact on subsequent relationships with clinicians and engagement in 
treatment. John‟s story, „It‟s all in Your Mind; You‟re a Hypochondriac‟, is about a 
consultation he had with a psychiatrist. He did not feel listened to and understood and 
disagreed with the treatment he was given: 
 
“I said “I don‟t want to take these tablets no more”, I said “they‟re making me feel worse 
instead of making me feel better and he [psychiatrist] said “I told you, it‟s all in your 
mind, you‟re a hypochondriac”. So that was it, I thought I‟ve had it with mental health”. 
 
Participants told stories about services that were not just unhelpful but “abusive”. John‟s 
story, „They Physically Beat Me‟, was particularly powerful. As an inpatient, he was 
“punched in the head, punched in the ribs, stamped on, [ ... ] hit with a liquid cosh 
[medication]” and then left in seclusion overnight on a cold floor with no blankets. In 
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„Professionals Can Be Uncaring Even Cruel‟, Sid spoke about negative attitudes and 
approaches of colleagues. He recounted a woman who arrived late to pick up her methadone 
prescription:  
 
“She [service user] was trying to get through the door. Her arm was through the door. 
She‟d tried to force her way in, and he [nurse] was leaning on her arm. And he was 
actually hurting her and saying “you know you‟re late. You were all told four o‟clock”. It 
was two minutes past four. Now I‟d be sceptical about ever going to that person [nurse]  
again.” 
 
Stories about the role of services in promoting engagement.  
There were 61 stories related to this theme. According to these stories, it is important 
service users feel listened to and understood, safe, accepted and not judged and that they are 
treated as individuals. In this regard, „therapeutic relationship‟ and issues around trust 
featured extensively. Once „therapeutic relationship‟ is established, according to participants‟ 
stories, other issues come into play such as setting out clear and realistic expectations of 
treatment, empowering services users, involving service users and their families in care 
planning, and specific interventions to increase problem awareness and coping skills. 
 
Due to issues around trust, it takes time for service users to feel safe in their relationships 
with clinicians. This is illustrated in the following excerpt from Anne‟s story „All You Can 
do is Trust‟:  
 
“ It‟s hard, you need some help and support, but you don‟t know who to trust. You don‟t 
always want to come here [current treatment]  because you have to face a lot of pain. And 
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is it really going to help in the long run? [ ... ]  The only thing you can do is you should 
trust in this team, is go along with it, because if you don‟t, like I said, you are going to go 
loopy or you‟re going to commit suicide. So I‟ve got no choice but to, to go for that help 
now” 
 
In her story, „Banging On‟, Jane spoke about allowing service users to address their 
„problems‟ when they are ready and on their terms. As an inpatient, John responded well to 
professionals who were willing to adapt Ward routines and treatments to take account of 
patients‟ needs and who listened and validated his concerns. This kind of approach and being 
consulted about his treatment made John “feel, yeah, special”. The following excerpt is from 
his story „They Involved Me in My Treatment Which Made Me Feel Special‟:  
 
“I don‟t sleep”, [ ... ] and I said [to a nurse] “but I‟ve never got any help”, so he went 
“right [ ... ] we‟re going to change your medication, John, you‟ve got to agree to this”, 
which I‟d never been asked to agree to. I‟ve just been told I‟ve got to take it”. 
 
In „I Bonded With My Psychologist Because He Did Not Judge Me‟, Tracey described the 
factors underpinning her positive relationship with her psychologist. Unlike previous 
unhelpful encounters with professionals, he took the time to get to know her as a person 
rather than making assumptions based on diagnostic labels and previous reports. Like Tracey, 
John values professionals who “know what they are talking about”. This is illustrated in his 
story „My Psychologist Understood My Problems‟: 
 
“and he [psychologist] like drew a diagram on the board of how your mood goes and how 
one leads to the other, and I went away and I looked at the board and I thought “that‟s 
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me” so he does know what he is talking about. Soon as I see that drawing and I knew that 
what he was saying that was me to a „T‟. Then I just sat back and I opened up.” 
 
Stories about how progress in treatment reinforces engagement.  
There were 11 stories in this theme, suggesting that progress in treatment reinforces 
motivation to engage and vice versa. In her story, „I‟m More Engaged in Treatment Because 
I‟m No Longer Attracted to the Danger of Drugs and Because My Self-Esteem Has 
Increased‟, Tracey said that the coping skills, sense of achievement and pride she gained 
through treatment was more important to her than the thrill of drugs: “After being a bit clean, 
maybe after being a month clean, I felt proud of myself, you know, I am worth it, I can do it, 
my self esteem is rising, why do I want that life?” 
 
In his story, „It‟s Nice That People Are Comfortable Around Me‟, John said that people 
perceive him differently since he has been in treatment, reinforcing his motivation to engage: 
“And it‟s nice to feel that people are comfortable around you, not laughing and joking with 
you because they feel they‟ve got to, you know, it‟s because they want to, and it‟s nice” 
 
Use of Language in the Telling of Stories and the Role of the Researcher in Co-
constructing Narratives. 
Use of language in the telling of stories (service user). 
Like the other service users interviewed, Anne tended to tell stories in the first person. 
Recapitulations and evaluations of events were re-enacted and emphasised using „direct 
speech‟, „repetitions‟ and „extended pauses‟. According to Riessman (2008), using language 
this way draws the listener in, recreating not only what happened but also the emotional 
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content. In addition to conveying key messages, linguistic features give stories credibility or 
believability. 
 
All the service users showed a tendency to take „disempowered‟ or „victimised‟ positions 
in their stories, except when they were speaking about their current treatment. At times, Anne 
became tearful, punctuating her speech with extended pauses. This was emotionally 
compelling, making it hard for the listener to not empathise with her difficult life experiences 
and relationship with services. Towards the end of her account, although still portraying 
herself as a victim, Anne grew in confidence, adopting a more assertive position in relation to 
the researcher and wider audiences. This was perhaps most evident in her story „Messed Up‟. 
In this story, she asked a series of questions of services and society, demanding to know why 
they treated her the way they did:  
 
“No one can really give me answers. All I know is that society has messed up. [ ... ]. Why I 
lost my children? Why I was put back to abusive, evil person [mother] ? [ ... ]  Why nobody 
come and checked properly? Why nobody heard my, my screams or crying for help? 
Why?” 
 
Use of language in the telling of stories (clinician). 
In contrast to service users, clinicians told more „us‟ and „they‟ stories. According to 
Robichaux and Clark (2006), this is not untypical of professional carers‟ accounts of service 
users‟ experiences. In Susan‟s case, „us‟ stories positioned her within her team and „they‟ 
stories were about service users, other services and to a lesser extent carers. 
 
54 
Running Head: Dual Diagnosis Treatment Motivation 
Reflecting their wealth of experience, clinicians told a comparatively high proportion of 
„habitual‟ (Riessman, 2008) or „overarching master‟ (Cain, 1991) narratives; generalisations 
based on repeated exposure to the same or similar events. According to Riessman (2008), 
habitual or „us‟ and „they‟ narratives make less of an impression than single case examples 
referring to specific people and events. The single case examples given by Susan tended to be 
brief and embedded within stories to illustrate particular points. She used them to highlight 
important shifts or „turning points‟ (Frank, 1995) in service users‟ treatment motivation and 
engagement. 
 
To further increase the „dramatic effect‟ of her single case examples, Susan told them in 
the service user‟s voice. Re-enacting rather than simply reflecting on events brought the 
researcher closer to what service users were thinking and feeling at the time. This use of 
language is illustrated in Susan‟s story, To Realise a Dream, about a service user who 
decided: “I am not getting any younger, I am in my mid-forties, I need to do something with 
my life, I want to write a book, this [cannabis] affects me”. 
 
With their specialist experience, the clinicians were accustomed to being consulted in this 
area, understood what to expect from the interview, and seemed empowered in their 
relationship with the researcher. As such, they asserted themselves throughout, speaking 
quickly and confidently. In Susan‟s account, there were minimal non-lexical utterances 
extended pauses, or inconsistencies indicative of „narrative tension‟, that is, “unresolved 
conflict or confusion regarding particular areas of experience” (Ayres, 2000, p. 362). 
However, she did use repetitions to alert the listener to what she was about to say or to 
emphasise important messages. The early part of her account about the nature of DD and her 
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work in this area was not in story form. It was interpreted as an „aside‟ where she “stepped 
out of the action to engage directly with the audience” (Riessman, 2008, p. 112). 
 
The role of the researcher in co-constructing narratives (service user). 
In her stories, Anne described a context in which she was prevented from being a „good 
mother‟, partly due to unhelpful interventions by services. Where necessary, she redirected 
the researcher‟s questions to stay on this topic. Despite difficulties with trust, it seemed Anne 
wanted to have a „voice‟, positioning the researcher as a witness to her strong feelings 
towards services. Occasional references to „society‟ suggested that she was also performing 
to wider audiences. 
 
With the exception of her current treatment, Anne cast herself in the role of „victim‟ and 
her mother, services, and wider society as the „abuser‟. It can be argued that attributing 
responsibility externally protected her „preferred identity‟ (Goffman, 1969) as a „good 
mother‟, offsetting feelings of guilt and shame. Also, it mitigated the risk of being judged 
harshly by the researcher. It is suggested here that dominant societal discourses around 
motherhood and associated pressures on women to fulfil certain expectations were embedded 
in Anne‟s stories and how they were told. 
 
On the whole, Anne‟s account can be described as a „tragedy‟ although there were 
glimmers of hope. In her closing stories about her current treatment, she portrayed herself and 
her care team as „heroic‟ characters, overcoming insurmountable odds. The extent to which 
interviewing Anne at the clinic where her current treatment is based impacted these stories is 
unclear. It is possible she inhibited her „true‟ feelings in order to protect the positive 
relationship she has with her care team. 
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The role of the researcher in co-constructing narratives (clinician). 
Side stepping my opening questions, Susan made evaluative statements about the complex 
nature of people with DD, providing a context to the stories she went on to tell and giving an 
indication as to how she wanted to be perceived by the researcher. As mentioned earlier, this 
part of her text was not in story form. Like the other clinicians interviewed, it seemed she was 
willing to be open about her shortcomings and the shortcomings of her team, provided they 
were judged fairly, taking into account the difficulties inherent in the work. 
 
Throughout their accounts, clinicians punctuated stories with „you know‟, implying shared 
knowledge. This positioned the researcher as a fellow „expert‟ or what Bell (1999) refers to 
as an „insider‟ and perhaps explains why their stories were not detailed and fully formed 
structurally as they might have been with a layperson. To some extent, all the clinicians used 
technical terms such as „harm minimisation‟ without defining what they mean. 
 
Towards the end of her account, Susan told “hypothetical narratives” (Riessman, 2008, p. 
2) about what she believed DD services could do differently to enhance treatment motivation 
and engagement. This can be seen as an indirect self-endorsement of her role and expertise in 
the area; something that would have been “difficult to say in other ways” (Riessman, 2008, p. 
112). At this point, she might have wondered about wider audiences and whether the study 
would have implications for her role within a DD pilot scheme. Although she omitted to 
mention it, she knew senior professionals within the Trust would have access to the results.  
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Discussion 
Findings in Relation to the Literature 
Story themes that provided explanatory answers to the research questions are summarised 
and discussed in relation to the literature on DD treatment models and models of treatment 
motivation, particularly Drieschner et al‟s (2004) „integral conceptualisation of treatment 
motivation‟. 
 
The sources or determinants of treatment motivation highlighted in the current study 
related to 1) significant life events and 2) a wish for change. Events such as pregnancy and a 
new „loving‟ relationship can be understood in terms of Drieschner et al‟s (2004) concepts of 
„outcome expectancy‟ while family „ultimatums‟ relate to „perceived external pressure‟. 
Stories about people accessing treatment due to medical problems, a near death experience, 
bereavement or when they „hit rock bottom‟ were typically about „problem recognition‟ and 
„level of suffering‟. These events and their impact on treatment motivation can be thought of 
as „turning points‟ which, according to Frank (1995), are integral in how people construct 
their experience of recovery. Stories about service users seeking treatment to fulfil a life 
ambition or because of personal pride stemmed from „a wish for change‟ rather than specific 
„turning points‟. With regards to Drieschner et al‟s (2004) model, they can be explained in 
terms of „outcome expectancy‟ and „problem recognition‟. 
 
Stories about the relationship between negative perceptions of services and treatment 
motivation were generally based on past unhelpful experiences of healthcare or what Brown 
(1998) refers to as „possibility turned to disappointment‟, that is, people being disbelieved, 
misunderstood, uncared for, stigmatised, neglected or victimised. This focus on the impact of 
services on treatment motivation is somewhat inconsistent with the predominant models of 
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motivation which tend to focus on the individual and personal responsibility for change 
(Kearney & O‟Sullivan, 2003; Heckhausen, 1991). The TTM (Prochaska & DiClemente, 
1982), particularly in the early stages of change, is primarily concerned with issues such as 
„problem recognition‟ and „self re-evaluation‟ while. Drieschner et al. (2004) argued that 
treatment motivation is based on „critical self-appraisal‟ of external forces rather than 
external forces themselves. According to Davis (2010), a social inclusion champion, the 
recovery process for some service users is at least partially based on “the realisation that 
external not personal factors were largely responsible for their plight” (p. 32) 
 
Stories about fluctuations in DD treatment motivation can be understood in terms of Miller 
and Rollnick‟s (2002) conceptualisation of ambivalence. The current study suggests that 
ambivalence arises when motivation for treatment is contingent on a range of competing 
variables simultaneously or „opposite pulls‟. This was illustrated in Isabel‟s story, 
„Disagreements Within Families‟, about a service user who was caught between his mother 
who supported treatment and his father who disapproved. Also, several stories described 
people who were aware of their problems and motivated to address them but unsure about 
treatment due to the „perceived costs‟ or its „perceived suitability‟ (Drieschner et al., 2004) 
based largely on past negative experiences of services. Within a motivational interviewing 
framework, impasses of this nature would be understood and targeted using „decision balance 
matrices‟ (Miller & Rollnick, 2002). 
 
The current study highlighted a range of individual factors that were thought to inhibit 
treatment engagement such as cognitive impairment, unrealistic expectations of services and 
issues around trust. Also, stories suggested that entering treatment and giving up „drugs‟ can 
be distressing and seem unrealistic, especially when they are integral to the person‟s sense of  
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identity, relationships and ability to cope. It is argued here that failure to take account of 
complex psychosocial issues like this can lead to differences of opinion within services and 
between services and service users regarding the nature of problems and what constitutes 
appropriate treatment. According to the literature, applying approaches such as motivational 
interviewing (Miller & Rollnick, 2002) and harm minimisation (Marlatt, 2002) that start 
treatment by focussing on service users‟ concerns as defined by them might minimise the 
likelihood of such misunderstandings. With people that have DD, unlike addiction only 
services, there is the added complication of fluctuating mental health conditions.  
 
The main focus of participants‟ stories regarding the impact of services on treatment 
engagement was on „therapeutic relationship‟. According to Drieschner et al. (2004), 
„therapeutic relationship‟ is not in itself a determinant of treatment motivation. However, it 
does target variables that are. In the current study, it was suggested that „therapeutic 
relationship‟ underpinned by client-centred principles (Rogers, 1959) such as empathic 
listening, acceptance and genuineness is important to offset the „perceived costs‟ of treatment 
and low „outcome expectancy‟ based on previous negative experiences of services. This 
association between „therapeutic relationship‟ and treatment engagement is consistent with 
the broader literature on addictions (e.g. Meier, Barrowclough & Donmall, 2005). Although 
inconclusive, Meier et al. (2005) argued “that a good therapeutic relationship may have 
particular importance in retaining drug using clients with psychiatric co-morbidity” (p. 12). 
 
Limitations 
If viewed from the positivist tradition, the outcomes of the current study do not infer cause 
and effect nor are they generalizable to other DD service users and clinicians. It is possible 
that the people who chose not to participate in the study were qualitatively different to those 
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that did. Also, the analysis was concerned with participants‟ reconstructions of experiences 
which are unique to them and by definition not replicable. However, the outcomes and how 
they are represented in story form can be used to help other clinicians and service users gain a 
more in-depth insight into their own roles and experiences (Polkinghorne, 1995). 
. 
The extent to which clinicians based their stories on preconceived ideas of treatment 
motivation from training and consulting with colleagues rather than direct experienced-based 
thoughts and feelings is hard to determine. Perhaps their stories were somewhat staged to 
give the impression they were familiar with the literature and best practice guidelines. 
Similarly, service users may have simply “parroted programme rhetoric” (Kearney & 
O‟Sullivan, 2003, p. 150) they had picked up through treatment. They may have censored 
what they said to avoid compromising current or future relationships with services. By the 
same token, due to previous unhelpful encounters with services, they may have been overly 
critical. As part of the analysis, an attempt was made to understand how the researcher and 
wider social discourses may have affected participants‟ stories. 
 
Transferability 
In essence, narrative analysis constitutes the researcher‟s interpretation of the participants‟ 
interpretation of their experiences conveyed through stories which could have been biased by 
a range of factors. As such, the researcher was reflexively aware of the personal and 
professional issues he brought to the interviews with participants that might have encouraged 
or impeded what was said. Applying Elliot's (2006) 'common sense' approach and Mishler's 
(1990) notion of 'trustworthiness', steps were taken maximise the internal consistency of the 
study to enable readers to make judgments about the transferability of findings to other 
contexts. 
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Clinical Implications 
The outcomes of the current study could have implications regarding the rates of people 
with DD seeking, accessing and engaging in treatment. A greater awareness and emphasis on 
motivation and the factors underpinning it can inform the configuration of integrated services 
and models of care planning to take account of a range of individual, contextual and 
relational factors in addition to diagnoses and severity of symptoms. Also, it might help 
address the lack of confidence, frustration and burnout that are all too familiar to clinicians 
working in this area (DiClemente et al., 2008). Equipping clinicians with the tools to assess 
and treat both mental health and substance use disorders might successfully challenge the 
culture that still exists within some services of „referring on‟. 
 
Models of motivation developed in the addictions field and applied to adult mental health 
such as the TTM and MI are primarily concerned with „problem recognition‟. Among people 
with DD, at least in the first instance, it might be better to focus on negative perceptions and 
low expectations of treatment due to previous unhelpful encounters with services. It is 
acknowledged that „therapeutic relationship‟ based on mutual trust, collaborative working 
and Rogerian (1959) client-centred principles has a pivotal role to play in most strands of 
healthcare. However, it is suggested here that it might be especially important for people with 
DD to help them overcome negative perceptions of services and to account for the chronic 
nature of the problems that often beset this client group, not least issues around trust and 
relating to others (Meier et al., 2005). 
 
Theoretical Implications 
Interventions such as CBT and MI have been adapted and incorporated into DD treatment 
programmes with encouraging results. Perhaps surprisingly given the low rates of treatment 
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uptake and engagement, little research has been carried out into the motivational processes 
that characterise this group. Although inconclusive, the outcomes of the current study offer 
some original contributions to the debate in the literature regarding the conceptualisation of 
motivation and associated models and treatments and how they can be evaluated and adapted 
specifically for people with DD. Based on the current study, the dimensions of motivation 
among people with DD are likely to be similar to addictions and other mental health related 
conditions. However, their relative influence and interaction effect might be different with 
particular emphasis on the link between outcome expectancy and the perceived match 
between the treatment and the service user‟s needs. Theoretically, this last point might help 
explain why problem awareness and motivation to change within this client group does not 
always translate into treatment uptake and engagement. 
 
Further Research and Conclusions 
This study offers insights into the factors that promote and inhibit DD treatment 
motivation and engagement. Most notably, there were several stories about people with DD 
wanting to address their difficulties but not wanting treatment due to previous negative 
experiences of services. On this basis, it could be argued that motivation to enter into and 
engage in DD treatment is a different form of motivation to the more generic concept of 
„readiness to change‟. This supports the notion that models of motivation developed in the 
addictions field and associated emphasis on „problem recognition‟ and personal responsibility 
for change fail to adequately account for the needs of DD groups. However, in order to draw 
firm conclusions, further research is required. 
 
Additional issues that might be of interest to the research community include: 1) 
similarities and differences in motivation across client groups; 2) interaction effects of 
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determinants of motivation and how their relative influence shifts over time and in different 
contexts; 3) how the interaction effects of dual and multiple disorders impact on treatment 
motivation and engagement; 4) „therapeutic relationship‟ and its link with DD treatment 
engagement. Based on the current study, this final point would seem important to help people 
overcome negative perceptions of professionals and treatment and associated difficulties with 
trust based on having felt let down by services in the past. 
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Abstract 
This paper provides a general overview of narrative research, including strengths and 
limitations as they relate to this study. With reference to the literature, clinical and theoretical 
implications are discussed along with recommendations for future research. The author‟s 
critical self-reflections regarding the process of initiating, carrying out and completing the 
study are highlighted.  Following this, there is a section on the ethical considerations of the 
study. Finally, the measures taken to ensure the quality of the study and maximise internal 
consistency are presented. 
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Critique of Study 
This was an exploratory study of a sample of eight service users‟ and clinicians‟ 
understandings of dual disorder (DD) treatment motivation, the factors underpinning it, and 
its relationship with treatment engagement. Part of the focus was on fluctuations in 
motivation over time and the meanings people ascribe to this. A qualitative design, from a 
social constructivist perspective, was thought to be appropriate for this study to gain a 
richness of data that would not be accessible using variable-based quantitative research. 
Narrative analysis in particular was chosen to highlight personal sense-making and to 
preserve the way people do this in their recounting of events, taking into account reciprocal 
relationships and meaning making processes and wider social and ideological influences. It 
seemed important to capture the way participants made sense of the complexity of 
interactions between motivation and their experiences of different elements of DD treatment 
and services, an area which has as yet been largely overlooked by the research community. 
 
Narrative Research 
Narrative analysis. 
Narrative analysis has roots in a range of scholarly and clinical domains as well as 
political movements such as feminism (Riessman, 2003). During the early and mid 20th 
century, a handful of psychologists argued that narrative analysis provided a deeper 
understanding of human experience and action than the predominant behavioural approaches 
of the time which were based on positivist ideology. According to the narrative approach, 
individuals make sense of their experiences and the world around them by setting them in 
story form. Recordings of narrative accounts within the stories people tell about their 
experiences are therefore the subject of analysis (Riessman, 2008). 
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The way narrative is defined determines the methods used to construct and analyse data 
(Mishler, 1995). Within the social sciences, there is no single definition of narrative and 
therefore no single definition of narrative analysis (Riessman, 1993). Some scholars view 
narratives as distinct units, “referring to brief, topically specific stories” (Riessman, 2003, p. 
1) which can be analysed in isolation of the social context in which they are embedded. 
Others argue that this definition is overly individualistic and that narratives need to be 
understood taking into account not only the „teller‟ but also the „listener‟ and surrounding 
social norms and discourses. 
 
Along these lines, Hinchman and Hinchman (1997) suggested that narratives “should be 
defined provisionally as discourses with a clear and sequential order that connect events in a 
meaningful way for a definite audience and thus offer insights about the world and/or 
people‟s experience of it” (p. xvi). Shaped by the socio-cultural landscape, narratives 
represent the stories people use in everyday life to construct, interpret and communicate 
personal experiences and sense of identity. In essence, storytelling is the means by which we 
understand “the „self‟ and our sense of others in the social world around us” (Bruner, 1986, p. 
69). Through analysis, these stories offer representations of personal experiences which, 
according to Riessman (2003, p. 15), are “fluid and contextual not fixed and universal”. 
Although there are different methods of narrative analysis, generally they share the view that 
narrative is about sequences of events unfolding temporally or causally in time (Riessman, 
2008). 
 
Why narrative analysis? 
As mentioned, according to the narrative approach, people describe and make sense of 
their world through stories. In medical education, Greenhalgh and Hurwitz (1999) interpret 
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case examples as in effect stories that have a certain power to convey important 
understandings. Through focussing on whole stories, narrative analysis does not fragment 
individuals‟ experiences into the smallest bits and pieces, separated from the context in which 
they are embedded. This underlying assumption of narrative analysis sets it apart from not 
only variable based research but also other qualitative methodologies such as grounded 
theory, interpretive phenomenological analysis (IPA) and purely discursive approaches 
(Mishler, 1995). Although open to debate, it is argued that preserving stories in their original 
form, as they are told and intended, represents more naturalistically the meaning people 
ascribe to their personal experiences, allowing research participants more control over the 
process of generating data and determining outcomes, than is generally the case with other 
methodologies (Murray, 2003). Giving participants control over what was appropriate and 
important to talk about was considered important in the current study due to the sensitive 
nature of the topic under investigation and to validate their experiences as defined by them. 
Also, it reflects the increasing popularity of research that seeks to get as close as possible to 
“first-hand experience and understanding” (Beresford, 2006, p. 169). 
 
Forms of narrative analysis. 
Riessman (2003) outlines three methods which have been found to be particularly useful 
for analysing orally presented narratives of personal experiences: thematic analysis, structural 
analysis and interactional analysis. Thematic analysis focuses on the content of narrative 
accounts. The linguistic properties of how stories are told do not feature in the investigation. 
In structural analysis, the emphasis is on not only what is said but how it is said. With 
interactional analysis, what is communicated and how is important; however, the focus is on 
context, particularly “the dialogic processes between teller and listener” (Riessman, 2003, p. 
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4). From this perspective, personal narratives are viewed as co-constructed between the teller 
and listener within the “broader social and cultural context” (Murray, 2003 p. 99). 
 
Riessman (2003) argues that there is overlap between the different methods described and 
that they can be used in combination. Applying the structural and interactional approaches, 
Bell‟s 1988 and 1999 studies explored identity transformation in two women who developed 
cancer as a result of their birth mothers being prescribed medication to reduce the risk of 
miscarriage. Core narratives and the links between them were identified and analysed 
thematically and linguistically using Labov‟s (1982) method to represent the experiences of 
these women before and after finding out they had cancer. The focus was on the narrative 
structures the women used to construct, link sequentially, and recapitulate topically relevant 
events within the interpersonal context of the research interview. This allowed for an in-depth 
exploration of how the relationship between these women and their doctors changed from one 
based primarily on medical discourses to one based more on the “women‟s health” (Bell, 
1999, p. 347) movement. 
 
Amongst other things, Bell‟s 1988 and 1999 studies illustrated the unfolding, multi 
complex, unique and contextual nature in which individuals make sense of health and health 
treatments. Similar to Bell (1999), the current study was interested in how understandings 
and relationships with services and treatment unfold over time in response to identity shifts 
and shifts in perspective based on wider social discourses. In this regard, structural analysis 
was used to outline the content of stories relevant to the research questions and how they 
were told linguistically. Additional analysis was used to understand how stories might have 
been influenced by the researcher and wider healthcare, social and political discourses. 
Themes were extracted from the structural analysis of interview transcripts to provide 
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“explanatory answers to the research questions” (Polkinghorne, 1995, p. 15) based on the 
authors “readings” (Bell, 1999, p. 353) of stories.   
 
Narrative interviews. 
Typically, research interviews have tended to discourage „story telling‟ (Murray, 2003), 
whereas in narrative research it is encouraged. According to Murray (2003), there are two 
kinds of narrative interview; „life history‟ and „episodic‟. The current study used the 
„episodic‟ approach which is more targeted. The emphasis was on the research questions 
guided by pre-existing theory, particularly Drieschner, Lammers and van der Staak (2004) 
„integral conceptualisation of treatment motivation‟. To start, participants were asked a 
„complex‟ question, outlining the issues under investigation and prompting them where to 
begin telling stories. Thereafter, to minimise researcher effects, the questions and prompts 
outlined in the interview schedules, or variations on them, were used selectively in response 
to the stories unfolding or to refocus participants if they became sidetracked. The interview 
schedules were piloted in advance and amended based on feedback from the Independent 
Research Review at Canterbury Christ Church University and through consulting with a 
Salomons Advisory Group of Experts by Experience (SAGE) member. 
 
Study Limitations 
Narrative analysis has been carried out with as few as two participants (Bell, 1999; Lee & 
Bonnie, 2006). On this basis, the current sample size of eight was considered sufficient to 
provide usable data. However, it is possible the clinicians who chose not to volunteer for the 
study did so due to factors that would have led them to tell different but no less relevant 
stories which has implications in terms of generalizability. The same can be said of people 
with DD who were not involved with services at the time and therefore unaware of the study. 
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Also, it is hard to determine the extent to which participants‟ stories were biased by 
“programme rhetoric” (Kearney & O‟ Sullivan, 2003) or the thought of compromising their 
work or the care they receive. For example, Tracey (service user) alone told eight separate 
but overlapping stories extolling the benefits of the psychological work she was engaged in. 
Through exploring dialogical processes, potential biases of this nature were not seen simply 
as a threat to the internal consistency of the study; rather an opportunity to gain insights into 
why participants told the stories they did (Bell, 1999). 
 
The stories and excerpts from stories selected and how they were understood as part of the 
analysis might have been substantively different had somebody else undertaken the study. 
Important “contexts shaping the researcher as interviewer and analyst” (Bell, 1999, p. 351) 
included prior knowledge of DD literature, clinical experience in the field and an inclination 
to advocate for approaches that empower service users. The latter potential bias may have led 
the researcher to make what Ayres (2000) refers to as moral rather than literary judgements. 
In this study, there were a number of stories from both service users and clinicians about 
unhelpful, sometimes punitive interventions by services. It is possible that these distressing 
accounts resonated with the researcher‟s own sense of frustration and disillusionment with 
DD services and treatments. The extent to which the researcher positioned himself alongside 
service users and in opposition to services needed to be understood and managed so as to 
inform rather than compromise how interviews were conducted, and the selection and 
interpretation of data. In this regard, regular meetings with the lead research supervisor for 
the purposes of independent validation were seen as essential, not only to maintain the 
integrity of the study but also as a learning experience within the context of the author‟s 
training. 
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Using Labov‟s (1982) structural method to identify and define narratives was challenging. 
Often participants dipped in and out of stories, making it difficult to determine where they 
began and ended. At other points, interesting and potentially valuable information was not in 
story form as defined by Labov‟s criteria. Despite not conforming strictly to Labov‟s system, 
partially formed, „habitual‟ and „hypothetical‟ narratives were considered in the analysis 
(Riessman, 2008). Habitual and hypothetical narratives were difficult to interpret using 
Labov‟s model because they did not centre round specific past events or experiences. 
Habitual narratives were about generalised experiences of the same or similar events whereas 
hypothetical narratives were precisely that (Riessman, 2008). Taking a flexible approach to 
the application of Labov‟s model was considered necessary in order to do justice to the 
breadth and depth of information provided by participants. 
 
Study Implications 
Clinical 
Models of motivation developed in the addictions field and applied clinically to DD and 
other aspects of adult mental health such as the TTM and MI are primarily concerned with 
„problem recognition‟. „Problem recognition‟ as a determinant of treatment motivation was 
reflected in clinicians‟ stories, for example, „Set in Their Ways‟ from Susan‟s account. In 
contrast, service user‟ stories suggested they were aware of their problems and wanted help 
but had doubts about the benefits of treatment due to past negative experiences. This raises 
two issues. First, service users and services might have different definitions of problems and 
what constitutes appropriate treatment. Second, at least in the first instance, it might be better 
to focus on negative perceptions and low expectations of treatment rather than „problem 
recognition‟. Of course, this is difficult to do when people are not in contact with services and 
reluctant to attend clinics. 
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With regards to treatment motivation and engagement, participants in this study seemed to 
be in agreement about the importance of „therapeutic relationship‟ and the service and 
clinician‟ qualities required to achieve it such as empathic listening, not jumping to 
conclusions about areas of difficulty, a caring respectful approach, seeing people as 
individuals and collaborative working. However, according to clinicians‟ stories, the 
relationship between these phenomena, „therapeutic relationship‟ and treatment uptake and 
engagement is not straightforward. As a result, there can be conflicted opinions among 
clinicians regarding the most appropriate configuration of services and interventions. 
 
 According to Jane and Isabel (clinicians), some teams support “intensive” and 
“persistent” approaches, for example visiting people at home. The counter argument was that 
this is “interfering [ ... ] sort of never leaving them alone” or that it encourages dependency 
and a lack of personal responsibility. They suggested that service users can be critical of 
approaches that are “compassionate and understanding” if ultimately they lack objectivity 
and credibility and are ineffective. This suggestion that there is a lack of consensus within 
and across services about the best methods of working with people with DD is consistent 
with a Delphi study carried out by Jeffery, Ley, Bennun and McLaren (2000). In the author‟s 
view, it illustrates the need for training to help teams develop a shared understanding of DD 
issues and appropriate treatments based on best practice guidelines (Department of Health, 
2002). 
 
Based on the current study, according to services users, it was the absence or perceived 
inappropriateness of input rather than its intensity that was unhelpful. Making it easier for 
people with DD to access or return to treatment on their terms might make services feel more 
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patient-centred and supportive, challenging some of the negative preconceptions that were 
highlighted. To account for and manage fluctuations in motivation, it might be helpful to 
develop drop-in treatments, employing brief motivational interviewing strategies which are 
recommended by the National Institute for Health and Clinical Excellence (NICE, 2007) for 
substance use, and more flexible approaches to closing cases due to missed sessions. In other 
areas of mental health, workshops in neutral settings such as leisure centres or libraries have 
been introduced in an effort to increase rates of treatment uptake among people that might 
otherwise not engage due to, for example, stigma (Brown, 1998). Davis (2010), based on 
interviews with mental health service users, highlights the importance of “working conjointly 
with people often vilified by society” (p. 32) in order to enable them to help themselves and 
combat their social exclusion and stigma. With this in mind, and based on the current study, it 
would seem important to establish shared understandings of service users‟ areas of difficulty 
and needs at the outset, before jointly deciding on a treatment plan. Also, it should not be 
assumed that people are unaware of their problems and lack motivation to change just 
because they choose not to access and engage in services.  
 
According to the literature, DD populations are more likely to have experienced abuse 
earlier in life than mental health and addictions service users generally (Lehman, Myers, 
Dixon & Johnson, 1994). Taking this into account, the number of stories in the current study 
regarding relational difficulties and trust is not surprising. To address this, workers with the 
skills and style of approach necessary to build positive relationships with DD service users 
would be of enormous value. In this regard, clinical psychologists with specialist knowledge 
in the area could have a role in training services in approaches such as MI, client-centred 
counselling and attachment based therapies (e.g. Reading, 2002) that pay particular attention 
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to the importance of therapeutic relationship. In line with the service user movement, service 
users themselves could be trained up to contribute to these initiatives. 
 
Theoretical 
As yet, the evidence base regarding DD treatment motivation and engagement is sparse 
and based almost exclusively on the TTM and associated measures, developed in addictions 
to explain stages and processes of change. This assumes that „addictions motivation‟ is the 
same as „DD motivation‟ and that „motivation to change‟ is the same as „treatment 
motivation‟ which, according to this and other studies, is not necessarily the case. This, 
among other conceptual ambiguities, calls into question the application of the TTM to people 
that have DD “despite its intuitive appeal to practitioners” (West, 2006, p. 1). Although 
inconclusive, the findings of the current study may contribute to the development of new 
models of treatment motivation and engagement and associated measures and treatments that 
relate specifically to DD populations. 
 
Based on the current study, as mentioned, the factors underpinning treatment motivation 
among people with DD are likely to be similar to addictions and other mental health related 
disorder. However, their relative influence and interaction effect might be different. There 
were numerous stories from participants in this study about service users feeling let down or 
even abused by services, leading to negative perceptions of professionals and treatment  in 
terms of compatibility and outcome expectancy. Theoretically, this last point might help 
explain the suggestion from this and other studies that problem awareness and motivation to 
change among people with DD does not always translate into treatment uptake and 
engagement. 
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In terms of the link between DD motivation to change and DD treatment entry and 
engagement, the current study would recommend models of DD treatment motivation and 
engagement pay particular attention to issues of trust. Difficulties with trust were highlighted 
repeatedly in stories across the whole sample. In this regard, consideration should be given to 
not only the person‟s past experience of services but also histories of sexual and physical 
abuse which are relatively common among addictions, leading to insecure patterns of relating 
and attachment (e.g. Duncan, Saunders, Kilpatrick, Hanson & Resnick, 1996). To help people 
understand and work through these difficulties, therapeutic relationship based on client-
centred (Rogers, 1959) principles and understandings of attachment theory might be of 
particular relevance to this group. 
 
Future Research 
Although inconclusive, outcomes of DD treatment programmes are encouraging. 
Arguably, as mentioned, the main problem is low rates of treatment uptake. To address this, it 
would seem important to understand the factors and processes underpinning treatment 
motivation and how they relate specifically to people with DD using models such as 
Drieschner et al‟s (2004) „integral conceptualisation of treatment motivation‟ as a framework 
to see if it offers a viable alternative to the TTM. The current study highlighted a number of 
issues that might provide important insights into these issues. However, further research is 
needed before firm conclusions can be drawn. 
 
Particular issues that might be of interest to the research community include: 1) 
similarities and differences between the generic concept of readiness to change and treatment 
motivation and engagement; 2) similarities and differences in motivation between people 
with DD and other client groups; 3) the interaction effects of determinants of DD motivation 
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and how their relative influence shifts over time and in different contexts; 4) how the 
interaction effects of dual and multiple disorders impact on treatment motivation and 
engagement; 5) „therapeutic relationship‟ and its link with DD treatment engagement taking 
into account issues such as fluctuating mental capacity and volitional control. 
 
As suggested by the current study, service users and clinicians might have different 
understandings of DD treatment motivation and engagement and the factors underpinning 
them. For example, individual variables such as mental capacity and lack of problem 
awareness featured in the stories by clinicians. In contrast, service users focussed more on the 
negative impact of services. As such, endorsed by the National Institute for Mental Health in 
England (NIMHE, 2005) and the recovery model (e.g. Shepherd, Boardman & Slade, 2008), 
it would seem important to gauge the views of both. Where possible, service user groups 
could be approached to contribute to the process of designing and carrying out research. In 
terms of methodology, qualitative or mixed qualitative and quantitative approaches are 
recommended. 
 
Researcher Reflexivity 
Research Idea 
The author first became interested in DD in the mid 1990‟s whilst working as a 
rehabilitation worker at a forensic psychiatric hospital. Two things were apparent at this time. 
Firstly, psychiatry was having difficulties adapting to the increased prevalence of drug use in 
this population. Secondly, there was a predominant discourse that drug use among people 
with mental disorder was an inconvenience because it interfered with traditional treatments 
and that it should be managed with sanctions and increased levels of security which seemed 
somewhat punitive. In response to this, the psychology department set up a substance misuse 
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service which the author went on to coordinate. In this capacity, part of the author‟s role was 
to develop psychological interventions for this group and to consult with staff around 
substance use and DD issues. 
 
At this time, reflecting the literature, most of what the author knew about DD and DD 
treatments stemmed from the addictions field. In the author‟s view, further research was 
needed specifically into DD. The current study, focusing on motivation to enter and then 
engage in treatment among people with DD, was influenced by two debates that emerged 
from the literature a few years later. One argument was that the TTM, which had come to 
dominate understandings of motivational processes, lacked clarity. Another argument 
suggested that motivational processes relating to DD treatment are different than motivational 
processes relating to addictions treatment and that they need to be understood and 
conceptualised independently. A particular frustration for the author was hearing people who 
had DD described as insightless and unmotivated because they did not attend and engage in 
treatment. This encouraged a culture of blame and stigmatisation and seemed like an overly 
simplistic view on what are complex issues, both in terms of individual factors and social 
context. 
 
Carrying Out the Study 
The initial stages of putting this study together ran smoothly. The lead and second 
supervisor seemed pleased to be involved in the project and the Salomons review board gave 
positive feedback as did NHS ethics. The author started to encounter difficulties going 
through R&D. This was partly due to changes in personnel within the department and partly 
due to a misunderstanding regarding a contract that had previously been set up between the 
Trust and Salomons to support the process. It was frustrating not being able to start recruiting 
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participants before the Christmas break 2009 as planned. The author understood that delays 
of this nature are a common experience when carrying out research of this nature. However, 
even at this early stage, he was mindful of the July deadline for completing the project.  
 
After approval from R&D, the author began recruiting participants. This process was beset 
by one delay after another. Directors and managers of services had expressed interest in the 
research itself which was encouraging. However, at a team level, there seemed to be 
numerous barriers. As part of the recruitment strategy, the author contacted team leaders, 
attended team meetings, e-mailed staff the external supervisor thought would be supportive, 
and met with dual diagnosis link workers that had been assigned to community adult mental 
health teams across the borough as part of an 18 month dual diagnosis pilot project. 
 
The plan originally was to interview clinicians or managers of services, service users, and 
carers of service users. In the first instance, the focus was on clinicians and managers. 
However, this proved more difficult than anticipated. Also, despite enthusiastic feedback 
about the study proposal, care coordinators seemed hesitant to introduce the author to service 
users and carers of service users. The reasons for this were never made explicit although the 
author could guess at some of them. The manager of one of the services had recently been 
appointed and was busy settling into the post and therefore not available to provide much 
assistance. All the services were in the process of completing a borough wide audit 
commissioned by the Trust which had been given high priority. The dual diagnosis pilot 
scheme within the borough was drawing to an end which meant that the link workers who 
had promised help were busy securing their futures. Also, there seemed to be a saturation of 
other research studies ongoing within the borough, competing for staff time and resources.  
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Completing the Study 
By the end of April 2010, it was becoming increasingly less likely that the study would be 
written up in time for the July deadline and that a rethink of the original study proposal was 
required. The author had several conversations with the research supervisors about changing 
the focus of the study in order to reach this deadline. Various modifications were considered 
as long as they did not deviate too much from the original focus. As a result, the author went 
back to NHS ethics and R&D with amendments to widen the pool of possible participants. 
With support from the study external supervisor, this proved successful and the author 
quickly managed to collect the data needed to complete the analysis and write up the project. 
Throughout this process, the support provided by the internal and external supervisors was 
greatly appreciated, giving the author the courage to request a deferment which was granted. 
In retrospect, this seems like the right decision to maintain as much as possible the integrity 
of the study as it was originally envisaged. Also, it afforded the author more time and more 
opportunities to gain invaluable experience developing and carrying out research within the 
NHS, particularly the importance of building relationships with services and professionals 
that can support the process. 
 
Ethical Considerations 
The study was approved by an Independent Research Review at Canterbury Christ Church 
University in April 2009, National Research Ethics Service (NRES) in October 2009, and 
NHS Foundation Trust Research and Development (R&D) in December 2009. Amendments 
to the original proposal, including the option of recruiting participants from across the Trust 
as opposed to a specific borough, were approved by NRES and R&D in May 2010. 
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Based on the inclusion criteria, people indentified as suitable for the study were given a 
„participant information sheet‟. Those interested were invited to meet the researcher to 
discuss the study in more detail including the format and expected duration of individual 
interviews, what would be required of them, issues of confidentiality and the use of data, and 
any other queries they may have had. If they still wanted to be involved, participants had the 
option of being interviewed straight away, provided 24 hours had elapsed since they first read 
the „participant information sheet‟, or at a later time if they wanted to think about it further. 
Prior to interviews, participants were required to read and sign a „consent form‟. 
 
According to the literature, most respondents welcome the open nature of narrative 
interviews, willingly sharing their stories. Others find the approach anxiety provoking 
(Greenall & Marselle, 2007). In the current study, part of the researcher‟s role was to put 
participants at ease, adopting an empathic and supportive approach. This was important in the 
current study due to the distressing nature of some of the stories told by service users. Anne 
in particular became upset speaking about her children being taken into care and how she felt 
let down by services in this regard. Where necessary, Anne and the other participants were 
reminded that they could take a break from the interview or withdraw their consent to 
participate at any time if they wished. Although not required, they were told that the 
researcher was available to speak with them after interviews about how they found it and any 
discomfort they may have felt. Alternatively, service users could speak with their care 
coordinators if they wished. In the „participant information sheet‟, a phone number was 
provided where the researcher could be contacted if there were any questions or concerns 
prior to or following meetings. 
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Quality Assurance Checks 
As mentioned earlier, the study outcomes are not generalizable to the wider population of 
service users with DD and professional carers working with DD. However, steps were taken 
to maximise the internal validity of the study to enable other researchers and clinicians to 
make reasonable judgments about the transferability of findings to other contexts. Based on 
Elliot's (2006) 'common sense' approach and Mishler's (1990) notion of 'trustworthiness', 
these steps included: 1) providing descriptions of participants and the research setting; 2) 
providing a description of the methodology used; 3) providing excerpts from texts; 4) making 
explicit how narratives were extracted and interpreted; 5) respondent validation; 6) 
independent validation. 
 
The purpose of respondent validation or correspondence (Riessman, 1993) is to ensure 
analysis of data fairly and accurately reflects what participants intended to convey. In this 
regard, participants in the current study were given a written summary of their stories and a 
feedback form to return to the author in a pre-paid envelope. The form invited participants to 
1) comment on how representative they felt the summary was of their interview and 2) bring 
to the author‟s attention any important information they neglected to mention at their 
interview. Unfortunately, only Tracey (service user) returned the form, saying that the 
analysis of her stories “was accurate”. In retrospect, follow-up telephone calls might have 
been helpful. 
 
In addition to Elliot‟s (2006) and Mishler‟s (1990) respective „common sense‟ and 
„trustworthiness‟ approaches, to further ensure transparency and to maximise the 
„persuasiveness‟ (Riessman, 1993) of the study to the wider research community and other 
interested parties, the interpretive evaluation of the researcher was taken into account at each 
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stage of the analysis (Mishler, 1995). This critique involved asking questions such as: 1) what 
information was included and omitted and why; 2) did the analysis remain true to the 
narrator's words; 3) how and to what extent have the researcher's interpretations of the data 
imposed on participants' stories? For independent validation, the analysis for one service user 
and one clinician was reviewed by the lead research supervisor. The lead research supervisor 
also read and commented on each section of the study write up for submission to the 
Salomons clinical training programme. 
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Appendix C 
 
CONSENT FORM 
 
Title of the research study 
What motivates people to enter and engage in „dual diagnosis‟ treatment: an analysis of 
service users‟, carers‟ and clinicians‟ and managers‟ opinions? 
 
Name of researcher 
Max Ward (trainee clinical psychologist) 
 
1. I confirm that I have read and understood the information sheet for the above study and 
have had the opportunity to ask questions.      
    
2. I understand that my participation in this study is voluntary and that I am free to withdraw 
at any time without giving any reasons and that this would not affect the health care I 
receive (currently or in the future), my legal rights, or my rights as an employee.  
 
       
3. I understand that the information I provide during this study will be kept confidential and 
secure in a locked filing cabinet or on a password protected computer. The only time 
confidentiality would be breached is if the researcher felt that you or somebody else was at 
risk of being harmed. This would include child welfare issues or crimes against the person, 
past and present.   
 
4. I understand that I will be interviewed as part of the study which will be audio-taped. 
 
 
5. I understand that the audio-tapes of my individual interview will be transcribed by either 
the main researcher or a professional transcriber. If used, the professional transcriber will 
be required to sign a confidentiality form. 
 
6. I understand that the audiotape from my individual interview and from the group meeting 
will be erased once the study is completed but that anonymised computer copies will be 
kept in a locked file for ten years before being destroyed.  
 
7. I understand that the main researcher will write a report about this study and a journal 
article and that these papers could include information taken from the anonymised copies 
of my individual interview and the group meeting, for example quotations. 
 
8. I understand that I am able to request a paper copy of my individual interview as well as a 
written summary of the findings from this study. 
 
Please sign below if you have ticked all of the above boxes and agree to take part in the 
study. 
 
______________________  _____________  _____________________ 
Name of participant   Date    Signature 
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Appendix D 
 
Interview Guide 
Co-existing Mental Disorder and Substance Use Treatment Motivation: service user 
perspective 
 
Briefing 
Thank you for agreeing to participate in this interview. Before we start, I would like to go 
over some of the information contained in the leaflet I gave you when we first met. First, you 
are free to stop the interview and withdraw your consent to participate in the study at any 
time. Second, you do not have to answer any questions you don‟t want to. Third, I will tape 
record the interview. Without this recording, it would be very difficult for me to remember all 
of what you talk about. Forth, everything you tell me will be kept confidential unless I 
thought you or somebody else was in danger of being harmed. Fifth, you will get the 
opportunity to comment on the results of this interview before they are written up into a 
paper. Is what I have said ok? Do you have any questions? 
 
Introduction 
As you are aware from our previous conversations, this study is about what motivates people 
to enter into dual diagnosis treatment and to engage in it. During the interview, I will ask you 
to tell me in your own words and based on your own experiences what you think about dual 
diagnosis and dual diagnosis treatment. To get you started, I will ask you a question. After 
that, I might prompt you from time to time to tell me more about the things you mention. As 
much as possible, I will try not to interrupt. This is because I am interested in hearing your 
life stories and what you think is important. Please feel free to speak openly and honestly and 
for as long as you think is necessary. I have set aside an hour and a half for this interview. It 
is ok if we finish early. If we need longer, we can arrange to meet again later today or at some 
other point in the next two weeks. Please let me know if you would like to take a break 
during the interview. At the end of the interview, you will get the opportunity to talk about 
how you found it and any discomfort you may have felt. 
 
Interview: opening question 
Can you tell me what it has been like for you living with both a mental health and a substance 
misuse disorder? I am particularly interested in the period from when you first experienced 
these problems to when you decided to start treatment with the X DD Team. Later on I would 
like to hear how you have found the treatment you receive from the X DD Team. I would like 
you to start at the beginning – from when you first began to have problems or difficulties. 
How old were you? .... What was happening at the time? .... ok, carry on .... then ....? 
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The objective of the interview is to get an overall picture of the participant‟s experiences of 
dual diagnosis. Within that, the emphasis is on eliciting stories about the nature and 
relationships between 1) determinants of motivation to engage in treatment i.e. a wish for life 
to be different, 2) motivation to engage in treatment itself i.e. what people do by way of 
entering treatment such as attending an initial appointment and 3) treatment engagement i.e. 
following or participating in a care plan. Special attention should be paid to how and for what 
reasons motivation to engage in treatment waxes and wanes over time. The following list of 
questions and prompts or variations on these questions and prompts will be used selectively 
to encourage the participant to further elaborate their stories or to refocus them on the issues 
under investigation should they become sidetracked. They will be used in response to the 
stories told by the participant rather than in a pre-planned way. 
 
Stage 1 questions: stories before X DD treatment 
 
What made you realise you had problems? 
 
What did you do next? 
 
And then...? What happened? 
 
How did people close to you react? 
 
When you first realised you had problems, what did you know about services or sources of 
help or support? How did you get to know about these services? What did you think when 
you first heard about that? Did you think you might be able to access help there? 
 
Can you tell me about the treatments you received before the X DD Team? 
 
Stage 2 questions: stories about entering X DD treatment 
 
How did you come to start treatment with the X DD Team? 
 
What was happening in your life at this time? 
 
What were your reasons for starting treatment with the X DD Team? 
 
Can you tell me about your motivation to start treatment? 
 
Describe for me a situation where your motivation was higher than usual. 
 
Describe a situation where your motivation was lower than usual. 
 
What stopped you from seeking treatment earlier? 
 
What needed to change before you decided to enter treatment? What brought about this 
change? 
 
What would have happened if things had stayed the same? 
 
What did people close to you think? 
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What were you hoping to get out of treatment? 
 
Stage 3 prompts/questions: stories about receiving X DD treatment 
 
What is your first memory of contact with the X DD Team? .... What happened after that? 
 
How does the X DD Team compare with the treatment you had previously? 
 
Does the treatment you receive meet your expectations? 
 
Are there times when you feel like stopping treatment? If so, could you give me an example 
of a time when you felt like that – what was happening at that time? 
 
In what ways has the treatment you receive from the X DD Team been helpful? 
 
Based on your needs, what would make the treatment better? 
 
In what ways are you satisfied with the treatment? 
 
In what ways are you satisfied with the treatment? 
 
In what ways are you dissatisfied with the treatment if at all? 
 
Prompts 
 
Can you tell me more about that? 
And what happened next? 
What were things like before you...? 
What were you thinking when...? 
What were you feeling inside when...? 
It sounds like when X happened you...? 
What was more important to you when...? 
In what way was X important...? 
What was your motivation like when...? 
What was that like? 
What did you mean when you said...? 
What helped when...? 
What did not help when...? 
Is there anything else you would like to say about that? 
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Appendix E 
 
Interview Guide 
Co-existing Mental Disorder and Substance Use Treatment Motivation: NHS clinician 
or manager perspective 
 
Briefing 
Thank you for agreeing to participate in this interview. Before we start, I would like to go 
over some of the information contained in the leaflet I gave you when we first met. As we 
discussed then, you are free to stop the interview and withdraw your consent to participate in 
the study at any time. Also, you do not have to answer any questions you don‟t want to. Here 
I have a Dictaphone. I will use it to tape record the interview. Without this recording, it 
would be very difficult for me to remember all of what you talk about. Everything you do talk 
about will be kept confidential unless I thought you or somebody else was in danger of being 
harmed. Finally, you will get the opportunity to comment on the results of this interview 
before the study is written up into a paper. Is what I have said ok? Do you have any 
questions? 
 
Introduction 
As you are aware from our previous conversations, this study is about what motivates people 
to enter into dual diagnosis treatment and to stay in it. During the interview, I will ask you to 
tell me in your own words and based on your own experiences what you think about dual 
diagnosis and dual diagnosis treatment. To get you started, I will ask a question. After that, I 
might prompt you from time to time to tell me more about the things you mention, but as far 
as possible, I will try not to interrupt. This is because I am interested in hearing your life 
stories and what you think is important. Please feel free to speak openly and honestly and for 
as long as you think is necessary. I have set aside an hour and a half for this interview. It is ok 
if we finish early. If we need longer, we can arrange to meet again later today or at some 
other point in the next two weeks. Please let me know if you would like to take a break 
during the interview. At the end of the interview, you will get the opportunity to talk about 
how you found it and any discomfort you may have felt. 
 
Interview: opening question 
Can you tell me about your experience working with people with both a mental health and a 
substance use disorder? I am particularly interested in what you think life is like for this client 
group during the period between first experiencing these difficulties and entering treatment 
with the X DD Team? I would also like your views on how the people you work with find the 
treatment they receive from the X DD Team. Please could you start with the first bit of the 
question – tell me about people‟s lives before entering treatment with X DD team –  what is 
your impression of this? ..... Go ahead. 
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The objective of the interview is to get an overall picture of the participants‟ experiences of 
dual diagnosis. Within that, the emphasis is on eliciting stories about the nature and 
relationships between 1) determinants of motivation to engage in treatment i.e. a wish for life 
to be different, 2) motivation to engage in treatment itself i.e. what people do by way of 
entering treatment such as attending an initial appointment and 3) treatment engagement i.e. 
following or participating in a care plan. Special attention should be paid to how and for what 
reasons motivation to engage in treatment waxes and wanes over time. The following list of 
questions and prompts or variations on these questions and prompts will be used selectively 
to encourage the participant to further elaborate their stories or to refocus them on the issues 
under investigation should they become sidetracked. They will be used in response to the 
stories told by the participant rather than in a pre-planned way. 
 
Stage 1 questions: stories before X DD treatment 
 
What is your impression of what makes the people you work with realise they have mental 
health and drug use problems? Does it tend to happen at the same time or…? 
 
What do they do when they realised they have problems with their mental health or drug use 
– or both?  
 
What is your impression of how people think about health and substance misuse services 
before entering treatment?  
 
What treatments have the people you work with received before entering the X DD Team if 
any? 
 
In what ways do people seem to have found previous treatments useful? 
 
In what ways do people seem to have found previous treatments unhelpful? 
 
Stage 2 questions: stories about entering X DD treatment 
 
How do the people you work with come to start treatment with the X DD Team? 
 
What is your impression of what life is like for clients in the weeks and months before they 
enter your service? 
 
What stopped the people you work with seeking treatment earlier? 
 
What would have happened if things had stayed the same? If they hadn‟t entered your 
service. 
 
What is it that needs to change before the people you work with decide to enter treatment? 
 
Can you tell me what motivated the people you work with to start treatment? 
 
What do the people close to the people you work with think about...? 
 
What do the people you work with hope to gain from treatment? 
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Stage 3 prompts/questions: stories about receiving X DD treatment 
 
What causes people to engage in the X DD Team treatment programmes? 
 
Are there times when the people you work with talk about stopping treatment? If so, could 
you tell me about them? 
 
What causes your clients to have difficulties engaging in the treatment you provide? 
 
What causes motivation to engage to fluctuate during treatment? 
 
What causes people to enter treatment but not engage? 
 
What causes people who are motivated to change drop out of treatment? 
 
Does the treatment you provide meet the expectations of your clients? 
 
In what ways has the treatment you provide been helpful? 
 
In what ways are the people you work with dissatisfied with their treatment? 
 
Prompts 
Can you tell me more about that? 
And what happened next? 
What were things like before you...? 
What were you thinking when...? 
What were you feeling inside when...? 
It sounds like when X happened you...? 
What was more important to you when...? 
In what way was X important...? 
What was your motivation like when...? 
What was that like? 
What did you mean when you said...? 
What helped when...? 
What did not help when...? 
Is there anything else you would like to say about that? 
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Appendix F 
 
[NHS Trust letter head removed to preserve anonymity] 
 
Study on why people go into and stick with treatment for ‘dual diagnosis’ - 
Invitation to take part 
 
This information is about a research study you may be interested in. 
 
What is the study about? 
The study is about what motivates people with dual diagnosis to start treatment and to stay in 
treatment. It is about service users‟ and NHS clinicians‟ and managers' views. 
 
Who is doing the study and why? 
My name is Max Ward and I am a trainee clinical psychologist. I am doing this study as part 
of my training and I am inviting you to take part. Before you decide it is important for you to 
understand why the research is being done and what you will be asked to do. Please take the 
time to read the following information carefully and discuss it with others if you wish. I have 
included my contact details at the bottom of the page if there is anything about the study that 
is not clear or if you would like more information. 
 
What is the purpose of the study? 
In the study I am interested in the reasons people start and then the reasons they stay in dual 
diagnosis treatment. I would like to hear the views of: 1) people who receive or have been 
offered treatment for their dual diagnosis, 2) NHS clinicians and managers working with dual 
diagnosis. 
 
What will I be asked to do if I take part? 
The first thing you will be asked to do is meet with me at your local specialist addictions or 
adult mental health clinic to discuss in person the information contained in this sheet. If you 
still want to be involved in the study, I will ask you to read and sign a consent form. After 
you have signed the consent form, I will interview you. You may want to do the interview 
straight away. If not, we can arrange to do it another time that is convenient for you. The 
interview itself will last up to an hour and a half and will take place at your local specialist 
addictions or adult mental health clinic. If we need longer, we can meet again the same day or 
at some other point within a two week period. In the interview, I will ask you to tell me in 
your own words and based on your own experiences what you think about dual diagnosis and 
dual diagnosis treatment. I am interested in the stories you have to tell about these issues. But 
you do not have to talk about things you don‟t want to. 
 
After I have completed all of the interviews, you and everybody else who participates in the 
study will be given a summary of what you told me and a feedback form. This will be an 
opportunity for you to comment on the results of the individual interviews and to discuss 
anything you think was missed. 
 
Expenses and payments 
Your travel expenses getting to and from individual and group meetings to participate in this 
study will be reimbursed. 
 
Are there any disadvantages of taking part? 
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It is unlikely you will be harmed in any way by taking part in this study. However, talking 
about periods in your life that were difficult and upsetting can cause some distress. For this 
reason, there will be time at the end of the interview for you to talk with me about how you 
found it and any discomfort you may have felt. If you are a service user, it can be arranged 
for you to speak with your mental health or specialist addictions care coordinator, although 
this might not happen straight away if they are otherwise engaged or absent from work. 
 
What do I do if there is a problem? 
There are three things you can do if you are unhappy about something to do with the study 
such as how you are treated whilst taking part. You can speak with me (24-hour answering 
service tel: XXX) to see if I can help. You can leave a message for me and I will pick it up 
and get back to you. Alternatively, you can contact either Dr Sue Holttum or Dr Tim Meynen 
(see details below) who are supervising the project. If you want to take the matter further, you 
can make a complaint through the NHS Complaints Procedure by going to the Department of 
Health website www.dh.gov.uk. 
 
Will my taking part in this study be kept confidential? 
All of the information you give me during the study will be kept confidential. The audiotape 
of your individual interview and the group meeting will be typed up by me or a professional 
transcriber, removing your name and certain other information such as your home town or 
other people or places you might mention. All audiotapes will be erased once the study is 
completed. Audiotapes and anonymous written accounts of audiotapes will be stored on my 
own personal computer at home and erased once the study is completed. They will be 
password protected which means nobody except me can access them. Paper copies of 
anonymous written accounts of audiotapes will be kept in a locked filing cabinet at my home 
and shredded once the study is completed. Following the study, anonymised typed copies of 
audiotapes will be password protected and stored on a CD which will be locked away on file 
at the university where I am doing my training for 10 years before being destroyed. 
 
There is a possibility I will ask my lead supervisor (Dr. Sue Holttum) to help me analyse 
what you tell me in the interview. If this happens, she will only get to see written copies of 
audiotapes with all identifiable information removed. Once the study is completed, I will 
write it up into a paper. This paper will be seen by two examiners from the clinical 
psychology training course I am doing. Some of what you tell me will be included in this 
paper along with information from other participants in the study. But nobody will know this 
information came from you. 
 
Though it is unlikely to be necessary, the only time I would break confidentiality is if I 
thought you or somebody else was in danger of being harmed as a result of something you 
told me. This would include child welfare issues and crimes against the person, past or 
present. In circumstances like this, I am duty bound to pass on the information to the 
appropriate people. But if possible I would discuss it with you first. 
 
What will happen to the results of the study? 
As I have mentioned, I will write up the results of the study into a paper. This paper will be 
examined by two examiners – one from my university and one from another university. 
Following this, an article will be submitted to a journal for publication. This article will be 
read by other health care professionals. It is an opportunity for them to learn from what you 
and other participants in the study tell me. It is also possible that the outcomes of this study 
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will be presented at professional meetings and conferences. In these reports there will be 
anonymous quotes from participants. 
 
The overall outcomes of the study will be given to you in writing once completed. 
 
Who is funding the research? 
The study is funded by Canterbury Christ Church University. 
 
Who has reviewed the study? 
Before going ahead, this study was reviewed and approved by an NHS Ethics Committee and 
the X Research and Development Programme. 
 
Contact details 
Main researcher: Max Ward (Trainee Clinical Psychologist) 
   Salomons Clinical Training Programme 
   Salomons Estate 
   Broomhill Road 
   Tunbridge Wells 
   TN3 0TG 
   (24 hour tel: XXX) 
 
Lead supervisor: Dr. Sue Holttum (Research and Teaching Psychologist) 
   Salomons Clinical Training Programme 
   Salomons Estate 
   Broomhill Road 
   Tunbridge Wells 
   TN3 0TG 
    
Second supervisor: Dr. Tim Meynen (Consultant Clinical Psychologist) 
[Address deleted to protect anonymity] 
    
 
THANK YOU for taking the time to read this information sheet. I look forward to meeting 
you should you decide to take part in the study. 
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Appendix G 
 
Study of why people go into and 
stick with treatment for ‘Dual 
Diagnosis’ 
 
Are you currently receiving treatment at X 
for ‘Dual Diagnosis’? 
 
If you have answered YES to this question, 
would you like to tell your story about what 
‘Dual Diagnosis’ means to you and about 
your experience of ‘Dual Diagnosis’ 
treatment?  
 
Please ask at reception for further 
information if you are interested in taking 
part in this study or contact Max Ward 
(Trainee Clinical Psychologist) on XXXX. 
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Appendix H 
 
“Example of research transcript has been removed from the electronic copy after 
examination” 
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Appendix I, J, K, L, M & N 
 
“Examples of narrative analysis using transcripts have been removed from the electronic 
copy after examination” 
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Appendix O 
 
“This has been removed from the electronic copy after examination” 
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Appendix P 
 
What motivates people to enter and engage in ‘dual diagnosis’ treatment: an analysis of 
service users’, clinicians’ and managers’ experiences 
PARTICIPANTS’ FEEDBACK ON THE SUMMARY OF THEIR RESEARCH 
INTERVIEW 
Please complete this form and return it to me in the pre-paid envelope provided. I would 
welcome any comments you might have on how well you think my summary of your 
research interview represents what you wanted to say? 
1) Please use the space below to mention things you agree or disagree with about my 
summary of your research interview. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Is there information you think might be useful for this research study that you 
did not mention in your interview? If so, please write it in the space below. 
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3) Do you have any general comments about my summary of your research interview? 
If so, please write them in the space below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this form. 
 
Kind regards, 
 
Max Ward 
Clinical Psychology Trainee 
Salomons Centre for Applied and Social Psychology Development 
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Appendix Q 
 
“This has been removed from the electronic copy after examination” 
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Appendix R 
 
“This has been removed from the electronic copy after examination” 
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Appendix S 
 
“This has been removed from the electronic copy after examination” 
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Appendix T 
 
“This has been removed from the electronic copy after examination” 
 
